Intersections of Substance Use, Overdose Risk, and Intimate Partner Violence: A Dyadic Approach to Violence Prevention in Criminal Legal Settings | Research Square window.SnipcartSettings = { analytics: { enabled: false } }; (function() { var accessVector = localStorage.getItem('access_vector') || ''; window.dataLayer = window.dataLayer || []; if (accessVector) { window.dataLayer.push({ user: { profile: { profileInfo: { snid: accessVector } } } }); } })(); (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-K279D39R'); Browse Preprints In Review Journals COVID-19 Preprints AJE Video Bytes Research Tools Research Promotion AJE Professional Editing AJE Rubriq About Preprint Platform In Review Editorial Policies Our Team Advisory Board Help Center Sign In Submit a Preprint Cite Share Download PDF Research Article Intersections of Substance Use, Overdose Risk, and Intimate Partner Violence: A Dyadic Approach to Violence Prevention in Criminal Legal Settings Dawn Goddard-Eckrich, Phillip Marotta, Nishita Dsouza, Mingway Chang, and 10 more This is a preprint; it has not been peer reviewed by a journal. https://doi.org/ 10.21203/rs.3.rs-6676375/v1 This work is licensed under a CC BY 4.0 License Status: Posted Version 1 posted You are reading this latest preprint version Abstract Background: When examining the relationship between intimate partner violence (IPV) and substance use, most studies have focused exclusively on individual-level correlates without considering cross-partner associations. Given the bidirectional nature of IPV within intimate relationships, a dyadic (couple) approach may assist in gaining a more precise understanding of the complex interrelationships between IPV, substance use, and overdose risks among couples. Methods: We employed the Actor-Partner Interdependence Model (APIM) using baseline data from a randomized controlled trial to examine how perpetration and experience of IPV in the past three months may be associated with substance use and non-fatal overdose risks among men in community supervision programs in New York City and their intimate partners (N=412 participants; 212 male and 196 female). The actor and partner effects were estimated using a multilevel logistic regression model with membership of a couple as a random effect for partner dependency, adjusting for key demographic factors. Findings: Over one-third of the participants (n=157, 38.1%) reported experiencing IPV and perpetrating IPV (n=149, 36.2%). Female participants who had been in the ER due to drugs or alcohol were more likely to report experiencing IPV (OR=2.62, 95% CI=1.02-6.88, p=0.046) and perpetrating IPV (OR=2.41, 95% CI=1.02-5.73, p=0.046) than those who had not been in the ER. Male participants who had been in the ER due to drugs or alcohol were also more likely to report perpetrating IPV (OR=3.07, 95% CI=1.31-7.16, p=0.010). Male participants who had experienced overdose were more likely to report perpetrating IPV than those who had not (OR=2.90, 95% CI=1.20, 7.01, p=0.018). No partner effects of overdose risks were significantly associated with participants’ reports of IPV. Implications for D&I Research: Our findings suggest a complex relationship between IPV and substance use behaviors, with primarily actor effects, but no significant partner effects. Understanding these relationships is important for developing integrated interventions that address both IPV and substance use risks among tice-involved populations. Such approaches may help address racial health inequities in drug overdose rates among non-Hispanic Black and Latinx populations, who are disproportionately impacted by the criminal legal system due to racialized drug laws and policing. Actor-Partner Interdependence Model IPV Couples drug use criminal legal system Figures Figure 1 Introduction Overview Recent research shows strong associations between experiences of intimate partner violence (IPV) and experiences of non-fatal drug overdose among different populations of women ( 1 – 3 ), including women in community supervision programs (CSPs). High rates of physical and sexual IPV ( 1 , 4 , 5 ) may contribute to the risks of overdose. After release from jail or prison, the risk of death from overdose is 12.7 times higher among men in the US than in the general population ( 6 ), highlighting the need to understand the associations between substance use disorder and IPV, especially among men in the criminal legal system. To date, no studies have examined the association between IPV (either experiencing or perpetrating) and non-fatal overdose among men in the criminal legal system. A systematic review by ( 7 ) highlighted the increased overdose risk associated with criminal legal involvement. Addressing overdose among criminal legal-involved individuals is crucial for reducing racial health disparities, as non-Hispanic Black and Latinx populations are disproportionately affected by overdose due to racialized drug laws and policing ( 8 ). Research on the relationships between IPV within couples and overdose risk among criminal legal-involved men and their partners is needed to address these co-occurring public health issues. Experiencing and perpetrating IPV behaviors IPV affects approximately one in three women and one in four men during their lifetime ( 9 ). While research has often focused on male perpetration and female victimization in heterosexual relationships, studies in specific contexts have shown that female-initiated violence can also occur at significant rates ( 10 – 12 ). Most female-to-male violence occurs within relationships characterized by bidirectional violence ( 13 , 11 , 14 ). However, the impact of this violence is not symmetrical; women are more likely to experience severe injuries, fear, and controlling behaviors from male partners than vice versa ( 13 , 15 ). IPV and Substance Use: Moving toward a dyadic approach Alcohol use disorders are most strongly associated with IPV perpetration, because alcohol impairs cognitive functioning, emotion regulation, and impulse control ( 16 – 20 ). Cocaine and methamphetamine use also increases IPV perpetration risk through similar disinhibition mechanisms and by inducing paranoia and aggression ( 21 , 22 ). The relationship between substance use and IPV was bidirectional. Substance use can increase IPV perpetration risk; conversely, IPV victimization can lead to increased substance use as a form of self-medication for physical and psychological trauma ( 23 – 25 ). While considerable research has examined how men's substance use contributes to IPV perpetration, women's substance use can also be associated with both victimization and perpetration, although these pathways are less researched ( 26 ). Most studies on IPV and substance use have focused exclusively on individual-level correlates, neglecting cross-partner associations ( 27 , 28 ). The actor-partner interdependence model (APIM) offers a more nuanced approach by examining both actor effects (how one's behavior predicts one’s own actions) and partner effects (how one's behavior influences one’s partner) ( 29 ). Another study found that veterans' drug abuse led to both their own IPV perpetration and their partners’ perpetration, although partner effects were not always reciprocal ( 30 ). Study Aims and Hypotheses To date, few studies have examined the effects of co-occurring IPV and non-fatal overdose at the couple level, with a scope for IPV that includes both victimization and perpetration. To our knowledge, this is the first study to apply the Actor-Partner Interdependence Model to examine both experiencing and perpetrating intimate partner violence among heterosexual couples where one partner is involved in the criminal legal system. While previous research has employed APIM to study other health behaviors among criminal legal-involved populations (Davis et al., 2020; Marotta et al., 2021a), none has specifically focused on the bidirectional nature of intimate partner violence and its association with substance use and overdose risk in this vulnerable population. With mounting evidence that IPV may be a risk factor for overdose, there is an urgent need to employ dyadic approaches, such as APIM, to identify patterns of how perpetrating and/or experiencing IPV may contribute to the risk of drug overdose in this population. This investigation is particularly relevant for those involved in the criminal legal system, given the overlap between racial health disparities, IPV, and overdoses for the population. To address this gap, this study employs APIM to examine how perpetration and experience of IPV may be associated with non-fatal overdoses among men in community supervision programs in New York City and their intimate partners. This study hypothesizes that non-fatal overdoses and substance use disorders are significantly associated with an increased likelihood of intimate partner violence (IPV) perpetration for both male and female offenders. Specifically: (H1) Male and female actors who experienced non-fatal overdoses and substance abuse had a significantly higher likelihood of self-reporting for a history of experiencing and/or perpetrating IPV (actor effects). (H2) Male partners who experienced non-fatal overdose and substance abuse had a significantly higher likelihood of female actors’ self-reports for a history of experiencing and/or perpetrating IPV (partner effects). (H3) Female partners who experienced non-fatal overdose and substance abuse had a significantly higher likelihood of male actors reporting a history of experiencing and/or perpetrating IPV (partner effects). Framework The present study employs the Actor-Partner Interdependence Model (APIM) as an analytical framework. This model is based on a dyadic conceptualization of health outcomes. Decades of research have linked the individual health outcomes of relationship partners to both the actions of the other partner and the functioning of the overall relationship. For example, individuals tend to benefit from mutually satisfying committed relationships because they are correlated with improved health outcomes and decreased harmful behaviors for both individuals in the relationship ( 31 ). The health outcomes of individuals within a relationship are thought to be interdependent and better understood within the context of the dyad. A dyad model allows the researcher to better recognize a partner's effects on an individual's health, identify any asymmetrical influences in which one partner has more influence on the health outcomes of both within the relationship, and examine both experiencing and perpetrating behaviors. However, using APIM allows for the operationalization of the dyad theoretical framework through the determination of the nature and effect of the patterns of interdependence within relationships ( 32 ). Intervention Design & Study Procedures Project Protect and Connect, also known as Project PACT, is a couple-focused HIV/STI prevention intervention that includes a randomized controlled trial investigating its efficacy in reducing sexual risk behavior. It was conducted between July 11, 2013, and May 17, 2016. In the current study, we conducted a secondary analysis using baseline data from this RCT. A detailed description of the study methods and sample characteristics is provided by ( 33 ). All study participants provided informed consent, and the study activities were approved by the Institutional Review Board at Columbia University. Two-hour PACT intervention sessions were delivered in a community supervision program setting. Core elements of the intervention (e.g., couple-based HIV testing and referral, problem-solving skills, strategies for reducing risky sexual behavior) are described elsewhere ( 33 , 34 ). The control arm consisted of individual rapid HIV/STI testing with pre- and post-test counseling and referrals to HIV/STI treatment and other health and/or social services. Randomized couples were randomized to either the intervention or control arm using a computer-generated randomization algorithm to balance the number of couples per study arm via an adaptive, biased-coin procedure ( 33 ). Assessments were performed at baseline, three, six, and 12-month follow-up post-intervention. The investigators were blinded to the treatment assignment until the final 12-month follow-up assessment. Participant Eligibility & Sample Recruitment The Columbia University graduate research assistants recruited participants from Community Correction Provider (CCP) locations in New York City. Eligibility screening included couples who met all of the following criteria: 1) both partners age 18 or older, 2) both partners identified each other as their primary sexual partner, 3) both partners reported a relationship duration of at least three months, 4) at least one partner reported having had condomless vaginal and/or anal intercourse with the primary sexual partner in the past 90 days, 5) at least one partner reported exposure or suspected their partner of exposure to an outside HIV risk (e.g., engaged in condomless sex with a different partner, shared syringes, tested positive for an HIV/STI) in the past year, 6) both partners reported that they plan to stay in a relationship with each other for at least another year, 7) the male partner reported either use of illicit drugs or binge drinking (i.e., consumed five or more alcoholic beverages on a single occasion) in the past 90 days, or attended substance abuse treatment in the past 90 days, 8) the male partner was mandated to community supervision, alternative to incarceration (ATI) or probation verified by court records ( 33 ). Participants were ineligible if they had cognitive or psychiatric impairments, were not proficient in English, or could not provide informed consent. In addition, 27 participants who reported having an order of protection against or felt unsafe completing the intervention with their partner, did not have a physical mail address, or lived more than 90 minutes from New York City were ineligible to participate. Participants were reimbursed up to $ 265 to complete all study procedures. The final analytical sample consisted of 206 heterosexual couples (412 individuals, 212 male and 196 female participants) with complete baseline data on the measures of interest ( 33 ). Measures Sociodemographics : Participants’ age, race/ethnicity (African American/Black or Hispanic/Latinx), education level (high school degree or higher/less than high school degree), marital status (single/married), employment status (employed/unemployed), homelessness in the past 90 days (yes/no), and food insecurity in the past 90 days (yes/no). Binge Drinking - Participants reported whether they had ever consumed five or more alcoholic drinks (for males) or four or more alcoholic drinks (for females) within a six-hour period (yes/no). This lifetime measure was used to capture patterns of problematic alcohol use that might be associated with IPV, which is consistent with the CAGE assessment timeframe. Alcohol Misuse - Participants responded to the four-item alcohol misuse CAGE questionnaire. Researchers categorized participant responses according to a cutoff of ≥ 2, which is considered clinically significant ( 35 ). Internal consistency in this sample was high (α = .95) ( 36 , 37 ). Illicit Drug Use - Participants reported lifetime use of heroin, cocaine, crack, speedball (a heroin and cocaine combination), methamphetamines, stimulants, non-prescribed tranquilizers, non-prescribed opiates, ecstasy, hallucinogens, and other drugs that were not prescribed. Participants who reported previous use of these substances were categorized as having used illicit drugs. Lifetime measures were used to maintain consistency with the DAST-10 assessment timeframe and capture patterns of drug use that might be associated with IPV. Overdose - Participants reported any lifetime overdose experience (yes/no) along with lifetime emergency room treatment for a drug or alcohol use-related problem (i.e., overdose, loss of consciousness, and injuries caused by drugs or alcohol) (yes/no). While we acknowledge the limitations of lifetime measures, they were chosen to ensure sufficient statistical power for analysis, as recent overdose events were relatively rare in this sample. Problematic drug use - Participants responded to the DAST-10 questionnaire, a measure of problematic illicit or non-prescribed drug use ( 38 ). Researchers coded any problematic substance use with a cutoff value of ≥ 3. Good internal consistency was demonstrated in this sample (α = .88). Intimate Partner Violence (IPV) - Experience and perpetration of IPV were assessed using a 16-item abbreviated version of the Revised Conflict Tactics Scale (CTS2) ( 39 ). Participants reported any incidents of psychological, physical, or sexual violence by their intimate partner in the previous three months. They also reported perpetration of these acts of violence against intimate partners during the same timeframe. Psychological violence included items such as insulting or swearing a partner; physical violence included items such as pushing, shoving, or slapping; and sexual violence included items such as using force or threats to have sex. The researchers assessed internal consistency with Cronbach's alpha (0.71 for experiencing IPV and 0.65 for perpetrating IPV). The lower alpha for perpetration may be due to 1) participants' discomfort in admitting perpetration and 2) gender differences in reporting patterns. Analysis Descriptive statistics for experiencing and perpetrating IPV were reported by sex. We also reported descriptive statistics for sociodemographic variables and substance use variables by gender and experience or perpetration of IPV. The chi-square test or t-test was used to test differences in characteristics between those who did and did not report IPV. To examine the actor and partner effects of substance use associated with experiencing and perpetrating IPV, we employed a multilevel logistic regression model with couples as random effects, to account for dependency within dyads. We analyzed experiencing and perpetrating IPV as separate outcome variables in distinct models. Each model included participants' reports and their partners' reports on one substance use variable at a time (to avoid multicollinearity between potentially correlated substance use measures), gender (coded male = 1 and female = 0), and interaction terms between gender and participant reports. The parameters associated with participants' reports represented the effects of substance use on female participants' IPV (female actor effect). We determined the actor effect of substance use on male participants' IPV by combining the parameters associated with participants' reports and the interaction term between sex and participants' reports. Similarly, we determined partner effects by analyzing how a partner's substance use affected the participant's IPV outcomes. Our primary models were adjusted for age and study arm assignment. We conducted sensitivity analyses, including additional covariates (ethnicity, education, and food security), to assess the robustness of our findings. Odds ratios (OR) were reported as actor and partner effects, and statistical significance was assessed using the associated 95% confidence interval (CI) and p-value at the level of 0.05. All statistical analyses were performed using Stata 15.1 In total, we estimated 12 separate models: six models examining the associations between different substance use measures and experiencing IPV and six models examining associations with perpetrating IPV. This approach allowed us to examine each substance use variable separately, while avoiding multicollinearity issues that would arise from including multiple correlated substance use measures in a single model. Results The data for this analysis were drawn from baseline assessments of 412 participants (196 female and 216 male) comprising 206 heterosexual couples. All male participants were involved in community supervision programs and reported binge drinking, illicit drug use, and/or attending drug treatment in the past 90 days according to the eligibility criteria. Table 1 presents the prevalence of experiencing and perpetrating IPV in the past three months among the study sample by gender. More than one-third of the participants (n = 157, 38.1%) reported experiencing IPV. A similar prevalence of IPV perpetration has also been reported (n = 149, 36.2%). There was no statistically significant difference in the prevalence of IPV between female and male participants. For example, 76 (38.8%) female and 81 (37.5%) male participants reported experiencing IPV, and 72 (36.7%) female and 77 (35.7%) male participants reported perpetrating IPV. Table 1 Prevalence of IPV by Gender Female Participant (n = 196) Male Participant (n = 216) Total (N = 412) Experiencing any IPV 76 (38.8%) 81 (37.5%) 157 (38.1%) Experiencing severe IPV 43 (21.9%) 34 (15.7%) 77 (18.7%) Perpetrating IPV 72 (36.7%) 77 (35.7%) 149 (36.2%) Perpetrating severe IPV 36 (18.4%) 36 (16.7%) 72 (17.5%) Regarding substance use patterns, the lifetime prevalence of illicit drug use was reported to be 56.1% in females and 63.4% in males. Binge drinking was reported in 46.4% of females and 55.6% of males. Problematic drug use (DAST ≥ 3) was indicated in 45.1% of females and 50.7% of males, whereas problematic alcohol use (CAGE ≥ 2) was present in 30.6% of females and 36.2% of males. A history of overdose was reported by 12.8% of females and 13.4% of males, and emergency room visits due to drug or alcohol problems were reported by 16.8% of females and 16.7% of males. Tables 2 a and 2 b present the sociodemographic characteristics of the full sample by sex. The mean age was 35.1 years for female participants and 35.7 years for male participants. Most participants were African American/Black (69.9% of females and 77.3% of males), followed by Hispanic/Latinx (19.4% of females and 19.4% of males). Educational attainment was similar across genders, with 67.3% of females and 64.4% of males reporting high school education or higher. Most participants were unmarried (59.7% of females and 57.9% of males) and unemployed (70.4% of females and 76.4% of males). Food insecurity was reported by 41.3% of females and 45.4% of males, whereas homelessness in the past 90 days was reported by 8.7% of females and 12.0% of males. In the group of male participants, 71.9% (n = 100) who did not perpetrate IPV completed high school, compared to 50.7% (n = 39) of who reported perpetration of IPV. A difference was also found in food security between female participants who did not report perpetration of IPV (n = 44, 35.5%) and those who did report perpetration of IPV (n = 37, 51.4%). Table 2 a: Sociodemographic characteristics by Experiencing IPV and by gender Experiencing IPV Female Participant Male Participant No (n = 120) Yes (n = 76) No (n = 135) Yes (n = 81) Age 36.2 (13.3) 33.0 (12.8) 36.6 (12.7) 34.2 (11.8) Ethnicity African American/Black 84 (70.0%) 51 (67.1%) 110 (81.5%) 56 (69.1%) Hispanic/Latino 25 (20.8%) 13 (17.1%) 22 (16.3%) 20 (24.7%) High school 78 (65.0%) 54 (71.1%) 92 (68.2%) 47 (58.0%) Marital status Single 75 (62.5%) 42 (55.3%) 76 (56.3%) 49 (60.5%) Married 35 (29.2%) 29 (38.2%) 49 (36.3%) 29 (35.8%) Currently unemployed 86 (71.7%) 51 (67.1%) 105 (77.8%) 60 (74.1%) Homeless in the past 90 days 7 (5.8%) 10 (13.2%) 15 (11.1%) 11 (13.6%) No enough money for food in the past 90 days 46 (38.3%) 35 (46.1%) 58 (43.0%) 40 (49.4%) * p < 0.05, ** p < 0.01 by two-tailed t-test or Chi-squared test Table 2 b: Sociodemographic characteristics by Perpetrating IPV and by gender Perpetrating IPV Female Participant Male Participant No (n = 124) Yes (n = 72) No (n = 139) Yes (n = 77) Age 35.9 (12.9) 33.3 (13.6) 35.1 (12.3) 36.9 (12.6) Ethnicity African American/Black 86 (69.4%) 49 (68.1%) 108 (77.7%) 58 (75.3%) Hispanic/Latino 24 (19.4%) 14 (19.4%) 27 (19.4%) 15 (19.5%) High school 86 (69.4%) 46 (63.9%) 100 (71.9%)** 39 (50.7%)** Marital status Single 75 (60.5%) 42 (58.3%) 84 (60.4%) 41 (53.3%) Married 40 (32.3%) 24 (33.3%) 49 (35.3%) 29 (37.7%) Currently unemployed 82 (66.1%) 55 (76.4%) 110 (79.1%) 55 (71.4%) Homeless in the past 90 days 10 (8.1%) 7 (9.7%) 15 (10.8%) 11 (14.3%) Tables 3 a and 3 b show the bivariate associations between IPV and substance use when analyzing data at the individual level divided by male and female participants. In Table 3 a (experiencing IPV), significant substance use differences emerged between those who did and did not report experiencing IPV. Among female participants, those experiencing IPV were significantly more likely to report emergency room visits due to drugs or alcohol (23.7% vs. 12.5%, p < 0.05) and problematic drug use as measured by DAST ≥ 3 (60.8% vs. 36.1%, p < 0.01). For male participants, experiencing IPV was associated with multiple substance use indicators including emergency room visits due to drugs or alcohol (23.5% vs. 12.6%, p < 0.05), problematic drug use (63.0% vs. 43.6%, p < 0.01), lifetime binge drinking (64.2% vs. 50.4%, p < 0.05), and problematic alcohol use as measured by CAGE ≥ 2 (45.5% vs. 30.9%, p < 0.05). Table 3 a: Bivariate association between IPV and substance abuse, breaking by gender Experiencing IPV: Female Participant Experiencing IPV: Male Participant No (n = 120) Yes (n = 76) No (n = 135) Yes (n = 81) Overdose: ever 13 (10.8%) 12 (15.8%) 16 (11.9%) 13 (16.1%) In ER due to drug or alcohol: ever 15 (12.5%)* 18 (23.7%)* 17 (12.6%)* 19 (23.5%)* Illicit drugs (excluding marijuana): ever 68 (56.7%) 42 (55.3%) 79 (58.2%) 58 (71.6%) DAST > = 3 (Problematic drug use) 43 (36.1%)** 45 (60.8%)** 58 (43.6%)** 51 (63.0%)** Binge drinking: ever 52 (43.3%) 39 (51.3%) 68 (50.4%)* 52 (64.2%)* CAGE > = 2 (Problematic alcohol use) 28 (26.9%) 27 (36.5%) 38 (30.9%)* 35 (45.5%)* * p < 0.05, ** p < 0.01 by Chi-squared test Table 3 b: Bivariate association between IPV and substance abuse, breaking by gender Perpetrating IPV: Female Participant Perpetrating IPV: Male Participant No (n = 124) Yes (n = 72) No (n = 139) Yes (n = 77) Overdose: ever 15 (12.1%) 10 (13.9%) 13 (9.4%)* 16 (20.8%)* In ER due to drug or alcohol: ever 16 (12.9%) 17 (23.6%) 16 (11.5%)** 20 (26.0%)** Illicit drugs (excluding marijuana): ever 67 (54.0%) 43 (59.7%) 80 (57.6%)* 57 (74.0%)* DAST > = 3 (Problematic drug use) 48 (38.7%)** 40 (58.0%)** 59 (42.8%)** 50 (65.8%)** Binge drinking: ever 51 (41.1%) 40 (55.6%) 69 (48.9%)** 52 (67.5%)** CAGE > = 2 (Problematic alcohol use) 28 (25.4%)* 27 (39.7%)* 38 (30.4%)* 35 (46.7%)* * p < 0.05, ** p < 0.01 by Chi-squared test Table 3 b reveals even stronger associations between substance use and perpetrating IPV, particularly for male participants. Among females, perpetrating IPV was significantly associated with problematic drug use (58.0% vs. 38.7%, p < 0.01) and problematic alcohol use (39.7% vs. 25.4%, p < 0.05). For male participants, all six substance use measures showed significant associations with IPV perpetration: lifetime overdose experiences (20.8% vs. 9.4%, p < 0.05), emergency room visits due to substances (26.0% vs. 11.5%, p < 0.01), illicit drug use (74.0% vs. 57.6%, p < 0.05), problematic drug use (65.8% vs. 42.8%, p < 0.01), binge drinking (67.5% vs. 48.9%, p < 0.01), and problematic alcohol use (46.7% vs. 30.4%, p < 0.05). These bivariate findings demonstrate pervasive associations between substance use and IPV, with males showing particularly strong and consistent relationships between substance use behaviors and IPV perpetration. Table 4 shows that female participants who had been in the ER due to drugs or alcohol were more likely to report experiencing IPV than those who had not been in the ER (OR = 2.62, 95% CI = 1.02–6.88, p = 0.046). Both female and male participants with DAST scores of 3 and above were more likely to report experiencing IPV in their lifetime than their male counterparts (OR = 3.89, 95% CI = 1.69-9.00, p = 0001 for females; OR = 3.07, 95% CI = 1.36, 6,96, p = 0.007 for males). No significant associations were found between their partners’ substance use behavior and the participants’ experience of IPV. Table 4 Actor-Partner Independence Models for Experiencing IPV on Substance Abuse as Independent Variable (IV): Odds ratio, 95% confidence intervals and p-values Outcome: Experiencing IPV Model 1 IV: Overdose: ever (n = 411) Model 2 IV: In ER due to drug or alcohol: ever (n = 411) Model 3 IV: Illicit drugs (excluding marijuana): ever (n = 411) Model 4 IV: DAST > = 3 (among drug users; n = 367) Model 5 IV: Binge drinking: ever (n = 411) Model 6 IV: CAGE > = 2 (among alcohol users; n = 341) Female actor effects Female actor’s substance abuse 1.53 [0.54, 4.35] (p = 0.416) 2.62* [1.02, 6.88] (p = 0.046) 0.86 [0.40, 1.84] (p = 0.699) 3.89** [1.69, 9.00] (p = 0.001) 1.55 [0.76, 3.19] (p = 0.229) 1.73 [0.79, 3.89] (p = 0.186) Male partner’s effects on female actors 1.59 [0.58, 4.35] (p = 0.366) 0.88 [0.34, 2.24] (p = 0.787) 1.24 [0.57, 2.72] (p = 0.592) 0.56 [0.25, 1.26] (p = 0.160) 0.63 [0.31, 1.29] (p = 0.208) 0.52 [0.24, 1.15] (p = 0.108) Male actor’s effects Male actor and his female partner 1.44 [0.54, 3.79] (p = 0.465) 2.42 [0.97, 6.06] (p = 0.059) 2.08 [0.94, 4.58] (p = 0.070) 3.07** [1.36, 6.96] (p = 0.007) 2.01 [0.99, 4.08] (p = 0.054) 1.70 [0.80, 3.60] (p = 0.164) Female partner’s effects on male partners 1.33 [0.47, 3.74] (p = 0.592) 1.26 [0.48, 3.30] (p = 0.644) 0.88 [0.42, 1.83] (p = 0.726) 0.73 [0.33, 1.62] (p = 0.441) 1.51 [0.75, 3.03] (p = 0.248) 1.66 [0.75, 3.67] (p = 0.211) * p < 0.05, ** p < 0.01 Table 5 . details perpetration among female participants, as being in the ER due to drug or alcohol (OR = 2.41, 95% CI = 1.02–5.73, p = 0.046), DAST scores equal to or greater than 3 (OR = 2.10, 95% CI = 1.07–4.14, p = 0.032), and binge drinking (OR = 1.94, 95% CI = 1.01, 3.73, p = 0.048) were significantly more likely to report IPV perpetration. Of the six multilevel models for male participants, five substance use variables were significantly associated with greater odds of reporting perpetrating IPV: overdose (OR = 2.90, 95% CI = 1.20, 7.01, p = 0.018), being in the ER due to drug or alcohol (OR = 3.07, 95% CI = 1.31–7.16, p = 0.010), illicit drug use (OR = 2.25, 95% CI = 1.09–4.63, p = 0.028), DAST score equal to or greater than 3 (OR = 2.36, 95% CI = 1.18–4.70, p = 0.015), and binge drinking (OR = 2.41, 95% CI = 1.25–4.63, p = 0.008). None of the partners’ substance use behaviors were significantly associated with participants’ reports of perpetration of IPV. Table 5 Actor-Partner Independence Models for Perpetrating IPV on Substance Abuse as Independent Variable (IV): Odds ratio, 95% confidence intervals and p-values Outcome: Perpetrating IPV Model 1 IV: Overdose: ever (n = 411) Model 2 IV: In ED due to drug or alcohol: ever (n = 411) Model 3 IV: Illicit drugs (excluding marijuana): ever (n = 411) Model 4 IV: DAST > = 3 (among drug users; n = 367) Model 5 IV: Binge drinking: ever (n = 411) Model 6 IV: CAGE > = 2 (among alcohol users; n = 341) Effect Type Female actor’s effect 1.04 [0.41, 2.66] (p = 0.924) 2.41* [1.02, 5.73] (p = 0.046) 1.21 [0.61, 2.40] (p = 0.578) 2.10* [1.07, 4.14] (p = 0.032) 1.94* [1.01, 3.73] (p = 0.048) 1.89 [0.91, 3.92] (p = 0.087) Male partner’s effects on female actors 1.77 [0.73, 4.30] (p = 0.210) 0.71 [0.30, 1.69] (p = 0.437) 1.14 [0.56, 2.30] (p = 0.725) 0.71 [0.36, 1.37] (p = 0.315) 0.78 [0.41, 1.49] (p = 0.453) 0.99 [0.49, 2.01] (p = 0.980) Effect Type Male actor effects 2.90* [1.20, 7.01] (p = 0.018) 3.07** [1.31, 7.16] (p = 0.010) 2.25* [1.09, 4.63] (p = 0.028) 2.36* [1.18, 4.70] (p = 0.015) 2.41** [1.25, 4.63] (p = 0.008) 1.81 [0.91, 3.58] (p = 0.089) Female partner’s effects on male actors 0.63 [0.24, 1.71] (p = 0.367) 0.89 [0.36, 2.19] (p = 0.797) 0.92 [0.47, 1.78] (p = 0.796) 1.42 [0.73, 2.78] (p = 0.304) 0.86 [0.46, 1.63] (p = 0.651) 1.98 [0.96, 4.09] (p = 0.064) * p < 0.05, ** p < 0.01 Discussion Our results revealed significant actor effects, where one's own substance use was associated with both experiencing and perpetrating IPV. For men under community supervision, problematic drug use was associated with experiencing IPV, while multiple substance use measures (overdose, emergency room visits, illicit drug use, problematic drug use, and binge drinking) were associated with perpetrating IPV. For women partnered with criminal legal-involved men, emergency room visits due to substance use and problematic drug use were associated with both experiencing and perpetrating IPV. Our findings identified significant sex differences in IPV and substance use associations. For women, experiencing IPV was significantly associated with emergency room visits and problematic drug use as measured by the DAST, whereas for men, experiencing IPV was only linked to problematic drug use. This suggests that women who experience IPV may use substances as coping mechanisms following victimization ( 23 , 25 ). Notably, we found no significant partner effects in our models examining IPV victimization, indicating that one's own substance use behaviors, rather than that of their partner, predicted their IPV experiences. For IPV perpetration, we found strong actor effects, but no significant partner effects. Men's perpetration was significantly associated with five substance use measures: overdose, emergency room visits, illicit drug use, problematic drug use, and binge drinking. Perpetration by women was associated with emergency room visits, problematic drug use, and binge drinking. These findings highlight substance use as a risk factor for IPV perpetration, potentially reflecting substance-induced disinhibition or underlying trauma contributing to both behaviors ( 16 ). Women experiencing IPV often face barriers in accessing harm reduction and treatment resources, including controlling behaviors from partners and limited healthcare access ( 4 , 3 ). The criminal legal system creates additional health inequities and barriers for overdose prevention. In the context of IPV, intimate partners may impede engagement with supervision requirements and inadvertently fuel mass supervision systems. Previous research using this dataset has demonstrated that couple-focused interventions can improve outcomes despite IPV exposure ( 3 , 40 ). Our Actor-Partner Interdependence Model also revealed strong actor effects but no significant partner effects, suggesting one's own substance use behaviors—rather than their partner's—predict involvement with family violence. This pattern extends previous APIM analyses from previous analysis on the PACT project, which similarly found significant actor effects for injection drug use ( 41 ) and sexual HIV risk behaviors ( 42 ). Future research should explore evidence-based violence reduction strategies, including mental health treatment, conflict resolution skills, and appropriate involvement in law enforcement during conflicts, as well as develop couple-focused interventions like adapting Project PACT to address overdose prevention within intimate partnerships, focusing on relationship communication, couple satisfaction, and trust as key mechanisms for behavioral change. Research is also needed to interrupt contexts where IPV occurs, as violence often occurs when partners are under the influence of substances. People who perpetrate violence may use substances during heightened emotional states without ensuring naloxone access, and may exclude partners from overdose prevention planning. Understanding how violence perpetration affects drug use behaviors is critical. Perpetrators may be less likely to engage in harm reduction practices during emotional distress and may disrupt coordinated efforts to reduce drug use. Further research should explore evidence-based violence reduction strategies, including mental health treatment, conflict resolution skills, and appropriate involvement in law enforcement during conflicts. Our findings and dyadic framework (Fig. 1 ) also illustrates how social determinants of health (sdoh) shape the dynamics of family violence and substance use among criminal legal-involved couples. The observed associations between housing instability, food insecurity, and IPV align with ( 43 ) research on how basic needs insecurity shapes health outcomes and ( 44 ) work demonstrating how stressful life events exacerbate both substance use and intimate partner conflict. The educational disparities we identified among male perpetrators align with findings from other criminal legal-involved populations where socioeconomic factors predicted both substance use and risk behaviors ( 40 ). These social determinants create a web of vulnerability where substance use and family violence become mutually reinforcing, supporting previous work on the intersectional nature of these challenges ( 1 ). These findings underscore the need for integrated approaches that simultaneously address substance use and IPV among criminal legal involved couples. Interventions should target both individual substance use behavior and relationship dynamics to effectively reduce IPV and substance-related harm in this vulnerable population. Limitations This study has several limitations that warrant consideration. First, our cross-sectional analysis, using only baseline RCT data, prevented causal inferences. The temporal relationship between substance use and IPV cannot be established with certainty, as substance use measures captured lifetime experiences, while IPV measures focused on the past three months. Second, self-reported data introduce potential recall and social desirability bias that could result in underreporting of both substance use and IPV. This may be particularly relevant for IPV perpetration, which shows a lower internal consistency reliability. Third, our sample selection criteria may have introduced biases that limit generalizability. Male participants were selected based on community supervision involvement and substance use, and couples were included based on HIV risk criteria, potentially resulting in a sample with higher rates of both substance use and IPV than those of the general population. Fourth, we examined each substance use variable in separate models to avoid multicollinearity; however, this approach does not account for the common co-occurrence of different substance use patterns. Finally, conclusions should be limited to heterosexual couples in which the male partner is involved in the criminal legal system in New York City. The data were collected between 2013–2016, and patterns of substance use and overdose risk have evolved substantially with the changing opioid crisis, particularly with the increased fentanyl prevalence in recent years. Conclusion This study addresses an important gap in the literature by examining the dyadic interplay between IPV and substance use among heterosexual couples, where the male partner is involved in community supervision. These findings highlight the need for approaches that simultaneously address substance use, family violence, and the underlying social determinants that contribute to both, particularly within criminal legal settings that serve populations disproportionately affected by these intersecting challenges. As community supervision increasingly serves as an alternative to incarceration for people who use drugs, understanding the complex relationships between substance use, IPV, and criminal legal system involvement is becoming increasingly important for developing effective interventions and policies, that can help reduce the public health burden of both IPV and substance use-related harm among families for this population. Declarations Funding This study was funded by the National Institute of Drug Abuse (grant reference number: R01DA033168). Two of the authors are supported by the National Institute on Drug Abuse of the National Institute of Health under Award Number T32DA037801. Clinical Trial Information Clinicaltrials.gov Trial Registration date : 2012-09-19. ClinicalTrials.gov ID: NCT01690494 Institutional Review Board Statement The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Research Board at Columbia University, for studies involving humans. Informed Consent Statement Informed consent was obtained from all subjects involved in the study. Data Availability Statement The data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy and ethical reasons. Acknowledgments The authors are very grateful to the New York City Department of Probation and the Center for Court Innovation. We also want to thank the facilitators of the PACT intervention as well as the project's research assistants. Finally, we wish to acknowledge the couples who participated in this study. Conflicts of Interest The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The funder had no role in any aspect of study design, study implementation, or analyses. Authorship contributions D.G.E, P.M, N.D., L.G, M.C, J.H, T.H., A.D - Writing – original draft and literature review; D.G.E, L.G, T.H, M.C - Data curation; N.E, L.G, E.W- Investigation; D.G.E L.G, E.W, M.C, A.D, T.H – Methodology; D.G.E, T.H, L.G, N.E - Project administration and Supervision; L.G, M.C, E.W., D.G.E - Conceptualization; N.E, L.G, E.W - Funding acquisition; D.G.E., P.M., N.D., M.C., E.W., A.R., T.H., A.D., A.D., J.H., S.B., K.C., N.E, L.G., .: review & editing. All authors have read, provided critical review and agreed to the published the manuscript. References Gilbert L, Marotta PL, Goddard-Eckrich D, Richer A, Akuffo J, Hunt T, et al. Association Between Multiple Experiences of Violence and Drug Overdose Among Black Women in Community Supervision Programs in New York City. J Interpers Violence. 2022;37(23–24):NP21502–24. Ataiants J, Mazzella S, Roth AM, Robinson LF, Sell RL, Lankenau SE. Multiple Victimizations and Overdose Among Women With a History of Illicit Drug Use. J Interpers Violence. 2022;37(3–4):NP1588–613. El-Bassel N, Marotta PL, Goddard-Eckrich D, Chang M, Hunt T, Wu E et al. Drug overdose among women in intimate relationships: The role of partner violence, adversity and relationship dependencies. Carrà G, editor. PLOS ONE. 2019;14(12):e0225854. Gilbert L, Goddard-Eckrich D, Hunt T, Ma X, Chang M, Rowe J, et al. Efficacy of a Computerized Intervention on HIV and Intimate Partner Violence Among Substance-Using Women in Community Corrections: A Randomized Controlled Trial. Am J Public Health. 2016;106(7):1278–86. Golder S, Hall MT, Logan T, Higgins GE, Dishon A, Renn T, et al. Substance Use Among Victimized Women on Probation and Parole. Subst Use Misuse. 2014;49(4):435–47. Waddell EN, Baker R, Hartung DM, Hildebran CJ, Nguyen T, Collins DM, et al. Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison. Health Justice. 2020;8(1):18. Van Draanen J, Tsang C, Mitra S, Karamouzian M, Richardson L. Socioeconomic marginalization and opioid-related overdose: A systematic review. Drug Alcohol Depend. 2020;214:108127. Urahn SK, Conroy T, Schiff M, Bell E, Chao S, Huh K et al. More Imprisonment Does Not Reduce State Drug Problems [Internet]. The Pew Charitable Trusts; 2018. Available from: https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2018/03/more-imprisonment-does-not-reduce-state-drug-problems Smith SG, Zhang X, Basile KC, Merrick MT, Wang J, Kresnow M et al. The National Intimate Partner and Sexual Violence Survey: 2015 data brief – updated release [Internet]. Centers for Disease Control and Prevention; 2018. Available from: https://stacks.cdc.gov/view/cdc/60893 Carney M, Buttell F, Dutton D. Women who perpetrate intimate partner violence: A review of the literature with recommendations for treatment. Aggress Violent Behav. 2007;12(1):108–15. Langhinrichsen-Rohling J, Misra TA, Selwyn C, Rohling ML. Rates of Bidirectional Versus Unidirectional Intimate Partner Violence Across Samples, Sexual Orientations, and Race/Ethnicities: A Comprehensive Review. Partn Abuse. 2012;3(2):199–230. Low S, Tiberio SS, Shortt JW, Capaldi DM, Eddy JM. Associations of couples’ intimate partner violence in young adulthood and substance use: A dyadic approach. Psychol Violence. 2017;7(1):120–7. Kimmel MS. Gender Symmetry in Domestic Violence: A Substantive and Methodological Research Review. Violence Women. 2002;8(11):1332–63. Straus MA. Dominance and symmetry in partner violence by male and female university students in 32 nations. Child Youth Serv Rev. 2008;30(3):252–75. Temple JR, Weston R, Marshall LL. Physical and Mental Health Outcomes of Women in Nonviolent, Unilaterally Violent, and Mutually Violent Relationships. Violence Vict. 2005;20(3):335–59. Foran HM, O’Leary KD. Alcohol and intimate partner violence: A meta-analytic review. Clin Psychol Rev. 2008;28(7):1222–34. Smith PH, Homish GG, Leonard KE, Cornelius JR. Intimate partner violence and specific substance use disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Addict Behav. 2012;26(2):236–45. Clements K, Schumacher JA. Perceptual biases in social cognition as potential moderators of the relationship between alcohol and intimate partner violence: A review. Aggress Violent Behav. 2010;15(5):357–68. O’Leary KD, Schumacher JA. The association between alcohol use and intimate partner violence: Linear effect, threshold effect, or both? Addict Behav. 2003;28(9):1575–85. Watkins LE, Maldonado RC, DiLillo D. Hazardous alcohol use and intimate partner aggression among dating couples: The role of impulse control difficulties. Aggress Behav. 2014;40(4):369–81. Ernst AA, Weiss SJ, Enright-Smith S, Hilton E, Byrd EC. Perpetrators of intimate partner violence use significantly more methamphetamine, cocaine, and alcohol than victims: a report by victims. Am J Emerg Med. 2008;26(5):592–6. Choenni V, Hammink A, Van De Mheen D. Association Between Substance Use and the Perpetration of Family Violence in Industrialized Countries: A Systematic Review. Trauma Violence Abuse. 2017;18(1):37–50. Gilbert L, El-Bassel N, Rajah V, Foleno A, Frye V. Linking drug-related activities with experiences of partner violence: a focus group study of women in methadone treatment. Violence Vict. 2001;16(5):517–36. Martino SC, Collins RL, Ellickson PL. Cross-lagged relationships between substance use and intimate partner violence among a sample of young adult women. J Stud Alcohol. 2005;66(1):139–48. Roberts TA, Klein JD, Fisher S. Longitudinal Effect of Intimate Partner Abuse on High-Risk Behavior Among Adolescents. Arch Pediatr Adolesc Med. 2003;157(9):875. Hien D, Hien NM, Women. Violence with Intimates, and Substance Abuse: Relevant Theory, Empirical Findings, and Recommendations for Future Research. Am J Drug Alcohol Abuse. 1998;24(3):419–38. Do QA, Knopp K, Scott SB. Intimate partner violence in female same-gender couples: An investigation of actor–partner correlates within the past year. Psychol Trauma Theory Res Pract Policy. 2022;14(5):759–68. Leone RM, Crane CA, Parrott DJ, Eckhardt CI. Problematic drinking, impulsivity, and physical IPV perpetration: A dyadic analysis. Psychol Addict Behav. 2016;30(3):356–66. Cook WL, Kenny DA. The Actor–Partner Interdependence Model: A model of bidirectional effects in developmental studies. Int J Behav Dev. 2005;29(2):101–9. Kelley ML, Lam N, Hernandez M, Miller MM, Mid-Atlantic VA. Workgroup. Modeling Risk for Intimate Partner Violence among Recent-Era Veteran-Partner Dyads. J Fam Violence. 2017;32(5):505–12. Newcomb MD. A Dyadic Approach to Health, Cognition, and Quality of Life in Aging Adults. Springer; 2020. Reed RG, Butler EA, Kenny DA. Dyadic Models for the Study of Health. Soc Personal Psychol Compass. 2013;7(4):228–45. El-Bassel N, Gilbert L, Goddard-Eckrich D, Chang M, Wu E, Goodwin S, et al. Effectiveness of a Couple-Based HIV and Sexually Transmitted Infection Prevention Intervention for Men in Community Supervision Programs and Their Female Sexual Partners: A Randomized Clinical Trial. JAMA Netw Open. 2019;2(3):e191139. Goddard-Eckrich D, Duan R, Hunt T, Wu E, Chang M, El-Bassel N. The impact of a couple-based intervention on HIV/STI testing among male-female couples who inject drugs. AIDS Behav. 2022;26(7):2316–26. Williams N. The CAGE questionnaire. Occup Med. 2014;64(6):473–4. Ewing JA. Detecting Alcoholism: The CAGE Questionnaire. JAMA. 1984;252(14):1905. Jensen N. Development of a novel measure to assess for alcohol misuse in older adults: The Alcohol Misuse Scale for Older Adults (AMSOA) [Internet] [Thesis]. Georgia Southern University; 2024. Available from: https://digitalcommons.georgiasouthern.edu/etd/2541 Skinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363–71. Straus MA, Hamby SL, BONEY-McCOY S, Sugarman DB. The Revised Conflict Tactics Scales (CTS2): Development and Preliminary Psychometric Data. J Fam Issues. 1996;17(3):283–316. Marotta PL, Terlikbayeva A, Gilbert L, Davis A, Wu E, Metsch L, et al. Dyadic analysis of criminal justice involvement and hiv risks among couples who inject drugs and their intimate partners in almaty, kazakhstan. Int J Drug Policy. 2021;87:102950. Davis A, Pala AN, Gilbert L, Marotta PL, Goddard-Eckrich D, El-Bassel N. Using actor-partner interdependence modeling to understand recent illicit opioid use and injection drug use among men in community supervision and their female partners in New York City. Int J Drug Policy. 2020;83:102843. Marotta PL, Gilbert L, Goddard-Eckrich D, Hunt T, Metsch L, Davis A, et al. A Dyadic Analysis of Criminal Justice Involvement and Sexual HIV Risk Behaviors Among Drug-Involved Men in Community Corrections and Their Intimate Partners in New York City: Implications for Prevention, Treatment and Policies. AIDS Behav. 2021;25(4):1047–62. Dsouza N, Gilbert L, Russo M, Johnson K, Chang M, Dasgupta A, et al. The Influence of Housing Status and Food Insecurity on a Behavioral HIV/STI Prevention Intervention for Black Women under Community Supervision in New York City: A Moderation Analysis. AIDS Behav. 2024;28(9):3161–9. Henry BF, Mandavia AD, Paschen-Wolff MM, Hunt T, Humensky JL, Wu E, et al. COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine. Psychol Trauma Theory Res Pract Policy. 2020;12(S1):S111–2. Additional Declarations No competing interests reported. Cite Share Download PDF Status: Posted Version 1 posted You are reading this latest preprint version Research Square lets you share your work early, gain feedback from the community, and start making changes to your manuscript prior to peer review in a journal. As a division of Research Square Company, we’re committed to making research communication faster, fairer, and more useful. We do this by developing innovative software and high quality services for the global research community. Our growing team is made up of researchers and industry professionals working together to solve the most critical problems facing scientific publishing. Also discoverable on Platform About Our Team In Review Editorial Policies Advisory Board Help Center Resources Author Services Accessibility API Access RSS feed Manage Cookie Preferences © Research Square 2026 | ISSN 2693-5015 (online) Privacy Policy Terms of Service Do Not Sell My Personal Information {"props":{"pageProps":{"initialData":{"identity":"rs-6676375","acceptedTermsAndConditions":true,"allowDirectSubmit":true,"archivedVersions":[],"articleType":"Research Article","associatedPublications":[],"authors":[{"id":459977902,"identity":"092a8f25-6451-4fc4-8fc1-5d3cbde9bfd8","order_by":0,"name":"Dawn Goddard-Eckrich","email":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAZAAAAAyAQMAAABI0h/eAAAABlBMVEX///8AAABVwtN+AAAACXBIWXMAAA7EAAAOxAGVKw4bAAAA4ElEQVRIie3PIQvCQBTA8QeDrRxencV9hSeiSfSrnAxMhksWg8KCxQ8wmx9BEMxvLFjEq4MVk8kwsC54Aw2WO6Pg/dsd78fjAbhcvxh5RBUOAQIAD7D5EjbiT7JUTpv5rwnr5azKXwS+IC21Q2KoIu6x/kHKEfBghkbSLq6CQiy724QNyhRjaG/uZoIFESGWAnNNGOpzCssWLLIVCby8yRLGVqIS0GvoTXLA0HqLD9kKY32LP9e3nFh4vkkjaSn1eNT1KOJBcixlvejwdbw3EgjF55uZx5s42WdcLpfrz3sCxjlMmkv1F5kAAAAASUVORK5CYII=","orcid":"","institution":"Columbia University","correspondingAuthor":true,"prefix":"","firstName":"Dawn","middleName":"","lastName":"Goddard-Eckrich","suffix":""},{"id":459977903,"identity":"5f0ab3e2-2f68-49f3-b358-30ad1f3f9723","order_by":1,"name":"Phillip Marotta","email":"","orcid":"","institution":"Washington University in St. Louis","correspondingAuthor":false,"prefix":"","firstName":"Phillip","middleName":"","lastName":"Marotta","suffix":""},{"id":459977904,"identity":"375f997c-5756-48ab-a62d-623e7b7319c1","order_by":2,"name":"Nishita Dsouza","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Nishita","middleName":"","lastName":"Dsouza","suffix":""},{"id":459977905,"identity":"d3dd714d-1cde-4ffd-8f3f-bc6a81fa9bbc","order_by":3,"name":"Mingway Chang","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Mingway","middleName":"","lastName":"Chang","suffix":""},{"id":459977906,"identity":"a5306897-4786-4a05-82d6-6d7eb69dd956","order_by":4,"name":"Elwin Wu","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Elwin","middleName":"","lastName":"Wu","suffix":""},{"id":459977907,"identity":"6fd7bd0e-6fe8-43fa-870d-9547d29cf4c8","order_by":5,"name":"Ariel Richer","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Ariel","middleName":"","lastName":"Richer","suffix":""},{"id":459977908,"identity":"9e83e378-aca9-4af0-bb8d-48dc32bd0f52","order_by":6,"name":"Timothy Hunt","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Timothy","middleName":"","lastName":"Hunt","suffix":""},{"id":459977909,"identity":"76a3a057-a7e6-4b78-bcf8-77724413d6d2","order_by":7,"name":"Alissa Davis","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Alissa","middleName":"","lastName":"Davis","suffix":""},{"id":459977910,"identity":"eb15f1ba-c7c0-4270-a48f-b91f985a6a62","order_by":8,"name":"Anindita Dasgupta","email":"","orcid":"","institution":"Columbia University Mailman School of Public Health, Department of Sociomedical Sciences,","correspondingAuthor":false,"prefix":"","firstName":"Anindita","middleName":"","lastName":"Dasgupta","suffix":""},{"id":459977911,"identity":"b4afbfa0-8d91-467f-937e-f38dc2dd4caf","order_by":9,"name":"Jennifer Hall","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Jennifer","middleName":"","lastName":"Hall","suffix":""},{"id":459977912,"identity":"98f8a38a-d9d0-4ceb-8e9b-4d61fbebbbf2","order_by":10,"name":"Sherna Alexander","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Sherna","middleName":"","lastName":"Alexander","suffix":""},{"id":459977913,"identity":"047566bb-40e3-4f44-a9ed-2eb769a71b2e","order_by":11,"name":"Kacey-Ann Cockett","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Kacey-Ann","middleName":"","lastName":"Cockett","suffix":""},{"id":459977914,"identity":"de72e31b-c8f7-4678-970f-9453e52f9578","order_by":12,"name":"Nabila El-Bassel","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Nabila","middleName":"","lastName":"El-Bassel","suffix":""},{"id":459977919,"identity":"9e5fb7d1-c3c6-4d66-9815-97a08278f018","order_by":13,"name":"Louisa Gilbert","email":"","orcid":"","institution":"Columbia University","correspondingAuthor":false,"prefix":"","firstName":"Louisa","middleName":"","lastName":"Gilbert","suffix":""}],"badges":[],"createdAt":"2025-05-16 02:23:18","currentVersionCode":1,"declarations":"","doi":"10.21203/rs.3.rs-6676375/v1","doiUrl":"https://doi.org/10.21203/rs.3.rs-6676375/v1","draftVersion":[],"editorialEvents":[],"editorialNote":"","failedWorkflow":false,"files":[{"id":83421072,"identity":"4e5cf883-39d9-4b20-adb9-9e6382143817","added_by":"auto","created_at":"2025-05-26 02:00:04","extension":"png","order_by":1,"title":"Figure 1","display":"","copyAsset":false,"role":"figure","size":548380,"visible":true,"origin":"","legend":"\u003cp\u003eLegend not included with this version.\u003c/p\u003e","description":"","filename":"1.png","url":"https://assets-eu.researchsquare.com/files/rs-6676375/v1/c63488071ecb4961dbc49c8f.png"},{"id":90562590,"identity":"6422c315-5b38-4b7e-bcb0-6adae9e4b4f4","added_by":"auto","created_at":"2025-09-04 06:32:01","extension":"pdf","order_by":0,"title":"","display":"","copyAsset":false,"role":"manuscript-pdf","size":1987597,"visible":true,"origin":"","legend":"","description":"","filename":"manuscript.pdf","url":"https://assets-eu.researchsquare.com/files/rs-6676375/v1/122fe154-67ce-4307-b005-6c9c0aa2aca1.pdf"}],"financialInterests":"No competing interests reported.","formattedTitle":"Intersections of Substance Use, Overdose Risk, and Intimate Partner Violence: A Dyadic Approach to Violence Prevention in Criminal Legal Settings","fulltext":[{"header":"Introduction","content":"\u003cdiv id=\"Sec2\" class=\"Section2\"\u003e \u003ch2\u003eOverview\u003c/h2\u003e \u003cp\u003eRecent research shows strong associations between experiences of intimate partner violence (IPV) and experiences of non-fatal drug overdose among different populations of women (\u003cspan additionalcitationids=\"CR2\" citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e), including women in community supervision programs (CSPs). High rates of physical and sexual IPV (\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e, \u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR5\" class=\"CitationRef\"\u003e5\u003c/span\u003e) may contribute to the risks of overdose. After release from jail or prison, the risk of death from overdose is 12.7 times higher among men in the US than in the general population (\u003cspan citationid=\"CR6\" class=\"CitationRef\"\u003e6\u003c/span\u003e), highlighting the need to understand the associations between substance use disorder and IPV, especially among men in the criminal legal system. To date, no studies have examined the association between IPV (either experiencing or perpetrating) and non-fatal overdose among men in the criminal legal system.\u003c/p\u003e \u003cp\u003eA systematic review by (\u003cspan citationid=\"CR7\" class=\"CitationRef\"\u003e7\u003c/span\u003e) highlighted the increased overdose risk associated with criminal legal involvement. Addressing overdose among criminal legal-involved individuals is crucial for reducing racial health disparities, as non-Hispanic Black and Latinx populations are disproportionately affected by overdose due to racialized drug laws and policing (\u003cspan citationid=\"CR8\" class=\"CitationRef\"\u003e8\u003c/span\u003e). Research on the relationships between IPV within couples and overdose risk among criminal legal-involved men and their partners is needed to address these co-occurring public health issues.\u003c/p\u003e \u003c/div\u003e \u003cdiv id=\"Sec3\" class=\"Section2\"\u003e \u003ch2\u003eExperiencing and perpetrating IPV behaviors\u003c/h2\u003e \u003cp\u003eIPV affects approximately one in three women and one in four men during their lifetime (\u003cspan citationid=\"CR9\" class=\"CitationRef\"\u003e9\u003c/span\u003e). While research has often focused on male perpetration and female victimization in heterosexual relationships, studies in specific contexts have shown that female-initiated violence can also occur at significant rates (\u003cspan additionalcitationids=\"CR11\" citationid=\"CR10\" class=\"CitationRef\"\u003e10\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR12\" class=\"CitationRef\"\u003e12\u003c/span\u003e). Most female-to-male violence occurs within relationships characterized by bidirectional violence (\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e, \u003cspan citationid=\"CR11\" class=\"CitationRef\"\u003e11\u003c/span\u003e, \u003cspan citationid=\"CR14\" class=\"CitationRef\"\u003e14\u003c/span\u003e). However, the impact of this violence is not symmetrical; women are more likely to experience severe injuries, fear, and controlling behaviors from male partners than vice versa (\u003cspan citationid=\"CR13\" class=\"CitationRef\"\u003e13\u003c/span\u003e, \u003cspan citationid=\"CR15\" class=\"CitationRef\"\u003e15\u003c/span\u003e).\u003c/p\u003e \u003c/div\u003e\n\u003ch3\u003eIPV and Substance Use: Moving toward a dyadic approach\u003c/h3\u003e\n\u003cp\u003eAlcohol use disorders are most strongly associated with IPV perpetration, because alcohol impairs cognitive functioning, emotion regulation, and impulse control (\u003cspan additionalcitationids=\"CR17 CR18 CR19\" citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR20\" class=\"CitationRef\"\u003e20\u003c/span\u003e). Cocaine and methamphetamine use also increases IPV perpetration risk through similar disinhibition mechanisms and by inducing paranoia and aggression (\u003cspan citationid=\"CR21\" class=\"CitationRef\"\u003e21\u003c/span\u003e, \u003cspan citationid=\"CR22\" class=\"CitationRef\"\u003e22\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eThe relationship between substance use and IPV was bidirectional. Substance use can increase IPV perpetration risk; conversely, IPV victimization can lead to increased substance use as a form of self-medication for physical and psychological trauma (\u003cspan additionalcitationids=\"CR24\" citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e\u0026ndash;\u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e). While considerable research has examined how men's substance use contributes to IPV perpetration, women's substance use can also be associated with both victimization and perpetration, although these pathways are less researched (\u003cspan citationid=\"CR26\" class=\"CitationRef\"\u003e26\u003c/span\u003e). Most studies on IPV and substance use have focused exclusively on individual-level correlates, neglecting cross-partner associations (\u003cspan citationid=\"CR27\" class=\"CitationRef\"\u003e27\u003c/span\u003e, \u003cspan citationid=\"CR28\" class=\"CitationRef\"\u003e28\u003c/span\u003e). The actor-partner interdependence model (APIM) offers a more nuanced approach by examining both actor effects (how one's behavior predicts one\u0026rsquo;s own actions) and partner effects (how one's behavior influences one\u0026rsquo;s partner) (\u003cspan citationid=\"CR29\" class=\"CitationRef\"\u003e29\u003c/span\u003e). Another study found that veterans' drug abuse led to both their own IPV perpetration and their partners\u0026rsquo; perpetration, although partner effects were not always reciprocal (\u003cspan citationid=\"CR30\" class=\"CitationRef\"\u003e30\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eStudy Aims and Hypotheses\u003c/p\u003e \u003cp\u003eTo date, few studies have examined the effects of co-occurring IPV and non-fatal overdose at the couple level, with a scope for IPV that includes both victimization and perpetration. To our knowledge, this is the first study to apply the Actor-Partner Interdependence Model to examine both experiencing and perpetrating intimate partner violence among heterosexual couples where one partner is involved in the criminal legal system. While previous research has employed APIM to study other health behaviors among criminal legal-involved populations (Davis et al., 2020; Marotta et al., 2021a), none has specifically focused on the bidirectional nature of intimate partner violence and its association with substance use and overdose risk in this vulnerable population.\u003c/p\u003e \u003cp\u003eWith mounting evidence that IPV may be a risk factor for overdose, there is an urgent need to employ dyadic approaches, such as APIM, to identify patterns of how perpetrating and/or experiencing IPV may contribute to the risk of drug overdose in this population. This investigation is particularly relevant for those involved in the criminal legal system, given the overlap between racial health disparities, IPV, and overdoses for the population. To address this gap, this study employs APIM to examine how perpetration and experience of IPV may be associated with non-fatal overdoses among men in community supervision programs in New York City and their intimate partners. This study hypothesizes that non-fatal overdoses and substance use disorders are significantly associated with an increased likelihood of intimate partner violence (IPV) perpetration for both male and female offenders. Specifically:\u003c/p\u003e \u003cp\u003e(H1) Male and female actors who experienced non-fatal overdoses and substance abuse had a significantly higher likelihood of self-reporting for a history of experiencing and/or perpetrating IPV (actor effects).\u003c/p\u003e \u003cp\u003e(H2) Male partners who experienced non-fatal overdose and substance abuse had a significantly higher likelihood of female actors\u0026rsquo; self-reports for a history of experiencing and/or perpetrating IPV (partner effects).\u003c/p\u003e \u003cp\u003e(H3) Female partners who experienced non-fatal overdose and substance abuse had a significantly higher likelihood of male actors reporting a history of experiencing and/or perpetrating IPV (partner effects).\u003c/p\u003e\n\u003ch3\u003eFramework\u003c/h3\u003e\n\u003cp\u003eThe present study employs the Actor-Partner Interdependence Model (APIM) as an analytical framework. This model is based on a dyadic conceptualization of health outcomes. Decades of research have linked the individual health outcomes of relationship partners to both the actions of the other partner and the functioning of the overall relationship. For example, individuals tend to benefit from mutually satisfying committed relationships because they are correlated with improved health outcomes and decreased harmful behaviors for both individuals in the relationship (\u003cspan citationid=\"CR31\" class=\"CitationRef\"\u003e31\u003c/span\u003e). The health outcomes of individuals within a relationship are thought to be interdependent and better understood within the context of the dyad. A dyad model allows the researcher to better recognize a partner's effects on an individual's health, identify any asymmetrical influences in which one partner has more influence on the health outcomes of both within the relationship, and examine both experiencing and perpetrating behaviors. However, using APIM allows for the operationalization of the dyad theoretical framework through the determination of the nature and effect of the patterns of interdependence within relationships (\u003cspan citationid=\"CR32\" class=\"CitationRef\"\u003e32\u003c/span\u003e).\u003c/p\u003e\n\u003ch3\u003eIntervention Design \u0026 Study Procedures\u003c/h3\u003e\n\u003cp\u003eProject Protect and Connect, also known as Project PACT, is a couple-focused HIV/STI prevention intervention that includes a randomized controlled trial investigating its efficacy in reducing sexual risk behavior. It was conducted between July 11, 2013, and May 17, 2016. In the current study, we conducted a secondary analysis using baseline data from this RCT. A detailed description of the study methods and sample characteristics is provided by (\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e). All study participants provided informed consent, and the study activities were approved by the Institutional Review Board at Columbia University.\u003c/p\u003e \u003cp\u003eTwo-hour PACT intervention sessions were delivered in a community supervision program setting. Core elements of the intervention (e.g., couple-based HIV testing and referral, problem-solving skills, strategies for reducing risky sexual behavior) are described elsewhere (\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e, \u003cspan citationid=\"CR34\" class=\"CitationRef\"\u003e34\u003c/span\u003e). The control arm consisted of individual rapid HIV/STI testing with pre- and post-test counseling and referrals to HIV/STI treatment and other health and/or social services. Randomized couples were randomized to either the intervention or control arm using a computer-generated randomization algorithm to balance the number of couples per study arm via an adaptive, biased-coin procedure (\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e). Assessments were performed at baseline, three, six, and 12-month follow-up post-intervention. The investigators were blinded to the treatment assignment until the final 12-month follow-up assessment.\u003c/p\u003e\n\u003ch3\u003eParticipant Eligibility \u0026 Sample Recruitment\u003c/h3\u003e\n\u003cp\u003eThe Columbia University graduate research assistants recruited participants from Community Correction Provider (CCP) locations in New York City. Eligibility screening included couples who met all of the following criteria: 1) both partners age 18 or older, 2) both partners identified each other as their primary sexual partner, 3) both partners reported a relationship duration of at least three months, 4) at least one partner reported having had condomless vaginal and/or anal intercourse with the primary sexual partner in the past 90 days, 5) at least one partner reported exposure or suspected their partner of exposure to an outside HIV risk (e.g., engaged in condomless sex with a different partner, shared syringes, tested positive for an HIV/STI) in the past year, 6) both partners reported that they plan to stay in a relationship with each other for at least another year, 7) the male partner reported either use of illicit drugs or binge drinking (i.e., consumed five or more alcoholic beverages on a single occasion) in the past 90 days, or attended substance abuse treatment in the past 90 days, 8) the male partner was mandated to community supervision, alternative to incarceration (ATI) or probation verified by court records (\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eParticipants were ineligible if they had cognitive or psychiatric impairments, were not proficient in English, or could not provide informed consent. In addition, 27 participants who reported having an order of protection against or felt unsafe completing the intervention with their partner, did not have a physical mail address, or lived more than 90 minutes from New York City were ineligible to participate. Participants were reimbursed up to \u003cspan\u003e$\u003c/span\u003e265 to complete all study procedures. The final analytical sample consisted of 206 heterosexual couples (412 individuals, 212 male and 196 female participants) with complete baseline data on the measures of interest (\u003cspan citationid=\"CR33\" class=\"CitationRef\"\u003e33\u003c/span\u003e).\u003c/p\u003e \u003cdiv id=\"Sec8\" class=\"Section2\"\u003e \u003ch2\u003eMeasures\u003c/h2\u003e \u003cp\u003e \u003cspan type=\"Underline\" class=\"Underline\" name=\"Emphasis\"\u003eSociodemographics\u003c/span\u003e: Participants\u0026rsquo; age, race/ethnicity (African American/Black or Hispanic/Latinx), education level (high school degree or higher/less than high school degree), marital status (single/married), employment status (employed/unemployed), homelessness in the past 90 days (yes/no), and food insecurity in the past 90 days (yes/no).\u003c/p\u003e \u003cp\u003e \u003cspan type=\"Underline\" class=\"Underline\" name=\"Emphasis\"\u003eBinge Drinking\u003c/span\u003e - Participants reported whether they had ever consumed five or more alcoholic drinks (for males) or four or more alcoholic drinks (for females) within a six-hour period (yes/no). This lifetime measure was used to capture patterns of problematic alcohol use that might be associated with IPV, which is consistent with the CAGE assessment timeframe.\u003c/p\u003e \u003cp\u003e \u003cspan type=\"Underline\" class=\"Underline\" name=\"Emphasis\"\u003eAlcohol Misuse\u003c/span\u003e - Participants responded to the four-item alcohol misuse CAGE questionnaire. Researchers categorized participant responses according to a cutoff of \u0026ge;\u0026thinsp;2, which is considered clinically significant (\u003cspan citationid=\"CR35\" class=\"CitationRef\"\u003e35\u003c/span\u003e). Internal consistency in this sample was high (α\u0026thinsp;=\u0026thinsp;.95) (\u003cspan citationid=\"CR36\" class=\"CitationRef\"\u003e36\u003c/span\u003e, \u003cspan citationid=\"CR37\" class=\"CitationRef\"\u003e37\u003c/span\u003e).\u003c/p\u003e \u003cp\u003e\u003cspan type=\"Underline\" class=\"Underline\" name=\"Emphasis\"\u003eIllicit Drug Use -\u003c/span\u003e Participants reported lifetime use of heroin, cocaine, crack, speedball (a heroin and cocaine combination), methamphetamines, stimulants, non-prescribed tranquilizers, non-prescribed opiates, ecstasy, hallucinogens, and other drugs that were not prescribed. Participants who reported previous use of these substances were categorized as having used illicit drugs. Lifetime measures were used to maintain consistency with the DAST-10 assessment timeframe and capture patterns of drug use that might be associated with IPV.\u003c/p\u003e \u003cp\u003e \u003cspan type=\"Underline\" class=\"Underline\" name=\"Emphasis\"\u003eOverdose\u003c/span\u003e - Participants reported any lifetime overdose experience (yes/no) along with lifetime emergency room treatment for a drug or alcohol use-related problem (i.e., overdose, loss of consciousness, and injuries caused by drugs or alcohol) (yes/no). While we acknowledge the limitations of lifetime measures, they were chosen to ensure sufficient statistical power for analysis, as recent overdose events were relatively rare in this sample.\u003c/p\u003e \u003cp\u003e \u003cspan type=\"Underline\" class=\"Underline\" name=\"Emphasis\"\u003eProblematic drug use -\u003c/span\u003e Participants responded to the DAST-10 questionnaire, a measure of problematic illicit or non-prescribed drug use (\u003cspan citationid=\"CR38\" class=\"CitationRef\"\u003e38\u003c/span\u003e). Researchers coded any problematic substance use with a cutoff value of \u0026ge;\u0026thinsp;3. Good internal consistency was demonstrated in this sample (α\u0026thinsp;=\u0026thinsp;.88).\u003c/p\u003e \u003cp\u003e\u003cspan type=\"Underline\" class=\"Underline\" name=\"Emphasis\"\u003eIntimate Partner Violence (IPV) -\u003c/span\u003e Experience and perpetration of IPV were assessed using a 16-item abbreviated version of the Revised Conflict Tactics Scale (CTS2) (\u003cspan citationid=\"CR39\" class=\"CitationRef\"\u003e39\u003c/span\u003e). Participants reported any incidents of psychological, physical, or sexual violence by their intimate partner in the previous three months. They also reported perpetration of these acts of violence against intimate partners during the same timeframe. Psychological violence included items such as insulting or swearing a partner; physical violence included items such as pushing, shoving, or slapping; and sexual violence included items such as using force or threats to have sex. The researchers assessed internal consistency with Cronbach's alpha (0.71 for experiencing IPV and 0.65 for perpetrating IPV). The lower alpha for perpetration may be due to 1) participants' discomfort in admitting perpetration and 2) gender differences in reporting patterns.\u003c/p\u003e \u003c/div\u003e\n\u003ch3\u003eAnalysis\u003c/h3\u003e\n\u003cp\u003eDescriptive statistics for experiencing and perpetrating IPV were reported by sex. We also reported descriptive statistics for sociodemographic variables and substance use variables by gender and experience or perpetration of IPV. The chi-square test or t-test was used to test differences in characteristics between those who did and did not report IPV.\u003c/p\u003e \u003cp\u003eTo examine the actor and partner effects of substance use associated with experiencing and perpetrating IPV, we employed a multilevel logistic regression model with couples as random effects, to account for dependency within dyads. We analyzed experiencing and perpetrating IPV as separate outcome variables in distinct models. Each model included participants' reports and their partners' reports on one substance use variable at a time (to avoid multicollinearity between potentially correlated substance use measures), gender (coded male\u0026thinsp;=\u0026thinsp;1 and female\u0026thinsp;=\u0026thinsp;0), and interaction terms between gender and participant reports.\u003c/p\u003e \u003cp\u003eThe parameters associated with participants' reports represented the effects of substance use on female participants' IPV (female actor effect). We determined the actor effect of substance use on male participants' IPV by combining the parameters associated with participants' reports and the interaction term between sex and participants' reports. Similarly, we determined partner effects by analyzing how a partner's substance use affected the participant's IPV outcomes.\u003c/p\u003e \u003cp\u003eOur primary models were adjusted for age and study arm assignment. We conducted sensitivity analyses, including additional covariates (ethnicity, education, and food security), to assess the robustness of our findings. Odds ratios (OR) were reported as actor and partner effects, and statistical significance was assessed using the associated 95% confidence interval (CI) and p-value at the level of 0.05. All statistical analyses were performed using Stata 15.1\u003c/p\u003e \u003cp\u003eIn total, we estimated 12 separate models: six models examining the associations between different substance use measures and experiencing IPV and six models examining associations with perpetrating IPV. This approach allowed us to examine each substance use variable separately, while avoiding multicollinearity issues that would arise from including multiple correlated substance use measures in a single model.\u003c/p\u003e"},{"header":"Results","content":"\u003cp\u003eThe data for this analysis were drawn from baseline assessments of 412 participants (196 female and 216 male) comprising 206 heterosexual couples. All male participants were involved in community supervision programs and reported binge drinking, illicit drug use, and/or attending drug treatment in the past 90 days according to the eligibility criteria. Table\u0026nbsp;\u003cspan refid=\"Tab1\" class=\"InternalRef\"\u003e1\u003c/span\u003e presents the prevalence of experiencing and perpetrating IPV in the past three months among the study sample by gender. More than one-third of the participants (n\u0026thinsp;=\u0026thinsp;157, 38.1%) reported experiencing IPV. A similar prevalence of IPV perpetration has also been reported (n\u0026thinsp;=\u0026thinsp;149, 36.2%). There was no statistically significant difference in the prevalence of IPV between female and male participants. For example, 76 (38.8%) female and 81 (37.5%) male participants reported experiencing IPV, and 72 (36.7%) female and 77 (35.7%) male participants reported perpetrating IPV.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab1\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 1\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003ePrevalence of IPV by Gender\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"4\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eFemale\u003c/p\u003e \u003cp\u003eParticipant\u003c/p\u003e \u003cp\u003e(n\u0026thinsp;=\u0026thinsp;196)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eMale\u003c/p\u003e \u003cp\u003eParticipant\u003c/p\u003e \u003cp\u003e(n\u0026thinsp;=\u0026thinsp;216)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eTotal\u003c/p\u003e \u003cp\u003e(N\u0026thinsp;=\u0026thinsp;412)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eExperiencing any IPV\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e76 (38.8%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e81 (37.5%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e157 (38.1%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eExperiencing severe IPV\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e43 (21.9%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e34 (15.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e77 (18.7%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003ePerpetrating IPV\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e72 (36.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e77 (35.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e149 (36.2%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003ePerpetrating severe IPV\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e36 (18.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e36 (16.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e72 (17.5%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eRegarding substance use patterns, the lifetime prevalence of illicit drug use was reported to be 56.1% in females and 63.4% in males. Binge drinking was reported in 46.4% of females and 55.6% of males. Problematic drug use (DAST\u0026thinsp;\u0026ge;\u0026thinsp;3) was indicated in 45.1% of females and 50.7% of males, whereas problematic alcohol use (CAGE\u0026thinsp;\u0026ge;\u0026thinsp;2) was present in 30.6% of females and 36.2% of males. A history of overdose was reported by 12.8% of females and 13.4% of males, and emergency room visits due to drug or alcohol problems were reported by 16.8% of females and 16.7% of males.\u003c/p\u003e \u003cp\u003eTables\u0026nbsp;\u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e2\u003c/span\u003ea and \u003cspan refid=\"Tab3\" class=\"InternalRef\"\u003e2\u003c/span\u003eb present the sociodemographic characteristics of the full sample by sex. The mean age was 35.1 years for female participants and 35.7 years for male participants. Most participants were African American/Black (69.9% of females and 77.3% of males), followed by Hispanic/Latinx (19.4% of females and 19.4% of males). Educational attainment was similar across genders, with 67.3% of females and 64.4% of males reporting high school education or higher. Most participants were unmarried (59.7% of females and 57.9% of males) and unemployed (70.4% of females and 76.4% of males). Food insecurity was reported by 41.3% of females and 45.4% of males, whereas homelessness in the past 90 days was reported by 8.7% of females and 12.0% of males. In the group of male participants, 71.9% (n\u0026thinsp;=\u0026thinsp;100) who did not perpetrate IPV completed high school, compared to 50.7% (n\u0026thinsp;=\u0026thinsp;39) of who reported perpetration of IPV. A difference was also found in food security between female participants who did not report perpetration of IPV (n\u0026thinsp;=\u0026thinsp;44, 35.5%) and those who did report perpetration of IPV (n\u0026thinsp;=\u0026thinsp;37, 51.4%).\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab2\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003ea: Sociodemographic characteristics by Experiencing IPV and by gender\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"4\" nameend=\"c5\" namest=\"c2\"\u003e \u003cp\u003eExperiencing IPV\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e \u003cp\u003eFemale Participant\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003eMale Participant\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;120)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;76)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;135)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;81)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAge\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003e36.2 (13.3)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u003cem\u003e33.0 (12.8)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e36.6 (12.7)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e34.2 (11.8)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eEthnicity\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAfrican American/Black\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e84 (70.0%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e51 (67.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e110 (81.5%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e56 (69.1%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eHispanic/Latino\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e25 (20.8%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e13 (17.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e22 (16.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e20 (24.7%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eHigh school\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e78 (65.0%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e54 (71.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e92 (68.2%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e47 (58.0%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMarital status\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eSingle\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e75 (62.5%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e42 (55.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e76 (56.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e49 (60.5%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMarried\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e35 (29.2%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e29 (38.2%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e49 (36.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e29 (35.8%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCurrently unemployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e86 (71.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e51 (67.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e105 (77.8%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e60 (74.1%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eHomeless in the past 90 days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e\u003cem\u003e7 (5.8%)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e\u003cem\u003e10 (13.2%)\u003c/em\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e15 (11.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e11 (13.6%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eNo enough money for food in the past 90 days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e46 (38.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e35 (46.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e58 (43.0%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e40 (49.4%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"5\"\u003e* p\u0026thinsp;\u0026lt;\u0026thinsp;0.05, ** p\u0026thinsp;\u0026lt;\u0026thinsp;0.01 by two-tailed t-test or Chi-squared test\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab3\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 2\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eb: Sociodemographic characteristics by Perpetrating IPV and by gender\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"4\" nameend=\"c5\" namest=\"c2\"\u003e \u003cp\u003ePerpetrating IPV\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e \u003cp\u003eFemale Participant\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003eMale Participant\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;124)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;72)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;139)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;77)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAge\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e35.9 (12.9)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e33.3 (13.6)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e35.1 (12.3)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e36.9 (12.6)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eEthnicity\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eAfrican American/Black\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e86 (69.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e49 (68.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e108 (77.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e58 (75.3%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eHispanic/Latino\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e24 (19.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e14 (19.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e27 (19.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e15 (19.5%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eHigh school\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e86 (69.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e46 (63.9%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e100 (71.9%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e39 (50.7%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMarital status\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eSingle\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e75 (60.5%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e42 (58.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e84 (60.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e41 (53.3%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMarried\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e40 (32.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e24 (33.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e49 (35.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e29 (37.7%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCurrently unemployed\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e82 (66.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e55 (76.4%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e110 (79.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e55 (71.4%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eHomeless in the past 90 days\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e10 (8.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e7 (9.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e15 (10.8%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e11 (14.3%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eTables\u0026nbsp;\u003cspan refid=\"Tab5\" class=\"InternalRef\"\u003e3\u003c/span\u003ea and \u003cspan refid=\"Tab5\" class=\"InternalRef\"\u003e3\u003c/span\u003eb show the bivariate associations between IPV and substance use when analyzing data at the individual level divided by male and female participants. In Table\u0026nbsp;\u003cspan refid=\"Tab5\" class=\"InternalRef\"\u003e3\u003c/span\u003ea (experiencing IPV), significant substance use differences emerged between those who did and did not report experiencing IPV. Among female participants, those experiencing IPV were significantly more likely to report emergency room visits due to drugs or alcohol (23.7% vs. 12.5%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05) and problematic drug use as measured by DAST\u0026thinsp;\u0026ge;\u0026thinsp;3 (60.8% vs. 36.1%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.01). For male participants, experiencing IPV was associated with multiple substance use indicators including emergency room visits due to drugs or alcohol (23.5% vs. 12.6%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05), problematic drug use (63.0% vs. 43.6%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.01), lifetime binge drinking (64.2% vs. 50.4%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05), and problematic alcohol use as measured by CAGE\u0026thinsp;\u0026ge;\u0026thinsp;2 (45.5% vs. 30.9%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05).\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab4\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003ea: Bivariate association between IPV and substance abuse, breaking by gender\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e \u003cp\u003eExperiencing IPV:\u003c/p\u003e \u003cp\u003eFemale Participant\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003eExperiencing IPV:\u003c/p\u003e \u003cp\u003eMale Participant\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;120)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;76)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;135)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;81)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eOverdose: ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e13 (10.8%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e12 (15.8%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e16 (11.9%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e13 (16.1%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eIn ER due to drug or alcohol: ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e\u003cb\u003e15 (12.5%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e\u003cb\u003e18 (23.7%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e17 (12.6%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e19 (23.5%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eIllicit drugs (excluding marijuana): ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e68 (56.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e42 (55.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e79 (58.2%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e58 (71.6%)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eDAST\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;3 (Problematic drug use)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e\u003cb\u003e43 (36.1%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e\u003cb\u003e45 (60.8%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e58 (43.6%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e51 (63.0%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eBinge drinking: ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e52 (43.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e39 (51.3%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e68 (50.4%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e52 (64.2%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCAGE\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;2 (Problematic alcohol use)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e28 (26.9%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e27 (36.5%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e38 (30.9%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e35 (45.5%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"5\"\u003e* p\u0026thinsp;\u0026lt;\u0026thinsp;0.05, ** p\u0026thinsp;\u0026lt;\u0026thinsp;0.01 by Chi-squared test\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab5\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 3\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eb: Bivariate association between IPV and substance abuse, breaking by gender\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"5\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"char\" char=\".\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c3\" namest=\"c2\"\u003e \u003cp\u003ePerpetrating IPV:\u003c/p\u003e \u003cp\u003eFemale Participant\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colspan=\"2\" nameend=\"c5\" namest=\"c4\"\u003e \u003cp\u003ePerpetrating IPV:\u003c/p\u003e \u003cp\u003eMale Participant\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;124)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;72)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eNo (n\u0026thinsp;=\u0026thinsp;139)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eYes (n\u0026thinsp;=\u0026thinsp;77)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eOverdose: ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e15 (12.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e10 (13.9%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e13 (9.4%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e16 (20.8%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eIn ER due to drug or alcohol: ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e16 (12.9%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e17 (23.6%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e16 (11.5%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e20 (26.0%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eIllicit drugs (excluding marijuana): ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e67 (54.0%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e43 (59.7%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e80 (57.6%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e57 (74.0%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eDAST\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;3 (Problematic drug use)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e\u003cb\u003e48 (38.7%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e\u003cb\u003e40 (58.0%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e59 (42.8%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e50 (65.8%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eBinge drinking: ever\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e51 (41.1%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e40 (55.6%)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e69 (48.9%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e52 (67.5%)**\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eCAGE\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;2 (Problematic alcohol use)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c2\"\u003e \u003cp\u003e\u003cb\u003e28 (25.4%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c3\"\u003e \u003cp\u003e\u003cb\u003e27 (39.7%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c4\"\u003e \u003cp\u003e\u003cb\u003e38 (30.4%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"char\" char=\".\" colname=\"c5\"\u003e \u003cp\u003e\u003cb\u003e35 (46.7%)*\u003c/b\u003e\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"5\"\u003e* p\u0026thinsp;\u0026lt;\u0026thinsp;0.05, ** p\u0026thinsp;\u0026lt;\u0026thinsp;0.01 by Chi-squared test\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eTable\u0026nbsp;\u003cspan refid=\"Tab5\" class=\"InternalRef\"\u003e3\u003c/span\u003eb reveals even stronger associations between substance use and perpetrating IPV, particularly for male participants. Among females, perpetrating IPV was significantly associated with problematic drug use (58.0% vs. 38.7%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.01) and problematic alcohol use (39.7% vs. 25.4%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05). For male participants, all six substance use measures showed significant associations with IPV perpetration: lifetime overdose experiences (20.8% vs. 9.4%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05), emergency room visits due to substances (26.0% vs. 11.5%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.01), illicit drug use (74.0% vs. 57.6%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05), problematic drug use (65.8% vs. 42.8%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.01), binge drinking (67.5% vs. 48.9%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.01), and problematic alcohol use (46.7% vs. 30.4%, p\u0026thinsp;\u0026lt;\u0026thinsp;0.05). These bivariate findings demonstrate pervasive associations between substance use and IPV, with males showing particularly strong and consistent relationships between substance use behaviors and IPV perpetration.\u003c/p\u003e \u003cp\u003eTable\u0026nbsp;\u003cspan refid=\"Tab6\" class=\"InternalRef\"\u003e4\u003c/span\u003e shows that female participants who had been in the ER due to drugs or alcohol were more likely to report experiencing IPV than those who had not been in the ER (OR\u0026thinsp;=\u0026thinsp;2.62, 95% CI\u0026thinsp;=\u0026thinsp;1.02\u0026ndash;6.88, p\u0026thinsp;=\u0026thinsp;0.046). Both female and male participants with DAST scores of 3 and above were more likely to report experiencing IPV in their lifetime than their male counterparts (OR\u0026thinsp;=\u0026thinsp;3.89, 95% CI\u0026thinsp;=\u0026thinsp;1.69-9.00, p\u0026thinsp;=\u0026thinsp;0001 for females; OR\u0026thinsp;=\u0026thinsp;3.07, 95% CI\u0026thinsp;=\u0026thinsp;1.36, 6,96, p\u0026thinsp;=\u0026thinsp;0.007 for males). No significant associations were found between their partners\u0026rsquo; substance use behavior and the participants\u0026rsquo; experience of IPV.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab6\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 4\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eActor-Partner Independence Models for Experiencing IPV on Substance Abuse as Independent Variable (IV): Odds ratio, 95% confidence intervals and p-values\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"6\" nameend=\"c7\" namest=\"c2\"\u003e \u003cp\u003eOutcome: Experiencing IPV\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eModel 1 IV:\u003c/p\u003e \u003cp\u003eOverdose: ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eModel 2 IV:\u003c/p\u003e \u003cp\u003eIn ER due to drug or alcohol: ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eModel 3 IV:\u003c/p\u003e \u003cp\u003eIllicit drugs (excluding marijuana): ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eModel 4 IV:\u003c/p\u003e \u003cp\u003eDAST\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;3 (among drug users; n\u0026thinsp;=\u0026thinsp;367)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eModel 5 IV:\u003c/p\u003e \u003cp\u003eBinge drinking: ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eModel 6 IV:\u003c/p\u003e \u003cp\u003eCAGE\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;2 (among alcohol users; n\u0026thinsp;=\u0026thinsp;341)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eFemale actor effects\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eFemale actor\u0026rsquo;s substance abuse\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1.53\u003c/p\u003e \u003cp\u003e[0.54, 4.35]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.416)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2.62*\u003c/p\u003e \u003cp\u003e[1.02, 6.88]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.046)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0.86\u003c/p\u003e \u003cp\u003e[0.40, 1.84]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.699)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e3.89**\u003c/p\u003e \u003cp\u003e[1.69, 9.00]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.001)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e1.55\u003c/p\u003e \u003cp\u003e[0.76, 3.19]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.229)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e1.73\u003c/p\u003e \u003cp\u003e[0.79, 3.89]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.186)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMale partner\u0026rsquo;s effects on female actors\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1.59\u003c/p\u003e \u003cp\u003e[0.58, 4.35]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.366)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e0.88\u003c/p\u003e \u003cp\u003e[0.34, 2.24]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.787)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1.24\u003c/p\u003e \u003cp\u003e[0.57, 2.72]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.592)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.56\u003c/p\u003e \u003cp\u003e[0.25, 1.26]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.160)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e0.63\u003c/p\u003e \u003cp\u003e[0.31, 1.29]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.208)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e0.52\u003c/p\u003e \u003cp\u003e[0.24, 1.15]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.108)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMale actor\u0026rsquo;s effects\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMale actor and his female partner\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1.44\u003c/p\u003e \u003cp\u003e[0.54, 3.79]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.465)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2.42\u003c/p\u003e \u003cp\u003e[0.97, 6.06]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.059)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2.08\u003c/p\u003e \u003cp\u003e[0.94, 4.58]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.070)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e3.07**\u003c/p\u003e \u003cp\u003e[1.36, 6.96]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.007)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e2.01\u003c/p\u003e \u003cp\u003e[0.99, 4.08]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.054)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e1.70\u003c/p\u003e \u003cp\u003e[0.80, 3.60]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.164)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eFemale partner\u0026rsquo;s effects on male partners\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1.33\u003c/p\u003e \u003cp\u003e[0.47, 3.74]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.592)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e1.26\u003c/p\u003e \u003cp\u003e[0.48, 3.30]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.644)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0.88\u003c/p\u003e \u003cp\u003e[0.42, 1.83]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.726)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.73\u003c/p\u003e \u003cp\u003e[0.33, 1.62]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.441)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e1.51\u003c/p\u003e \u003cp\u003e[0.75, 3.03]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.248)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e1.66\u003c/p\u003e \u003cp\u003e[0.75, 3.67]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.211)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"7\"\u003e* p\u0026thinsp;\u0026lt;\u0026thinsp;0.05, ** p\u0026thinsp;\u0026lt;\u0026thinsp;0.01\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e \u003cp\u003eTable\u0026nbsp;\u003cspan refid=\"Tab7\" class=\"InternalRef\"\u003e5\u003c/span\u003e. details perpetration among female participants, as being in the ER due to drug or alcohol (OR\u0026thinsp;=\u0026thinsp;2.41, 95% CI\u0026thinsp;=\u0026thinsp;1.02\u0026ndash;5.73, p\u0026thinsp;=\u0026thinsp;0.046), DAST scores equal to or greater than 3 (OR\u0026thinsp;=\u0026thinsp;2.10, 95% CI\u0026thinsp;=\u0026thinsp;1.07\u0026ndash;4.14, p\u0026thinsp;=\u0026thinsp;0.032), and binge drinking (OR\u0026thinsp;=\u0026thinsp;1.94, 95% CI\u0026thinsp;=\u0026thinsp;1.01, 3.73, p\u0026thinsp;=\u0026thinsp;0.048) were significantly more likely to report IPV perpetration. Of the six multilevel models for male participants, five substance use variables were significantly associated with greater odds of reporting perpetrating IPV: overdose (OR\u0026thinsp;=\u0026thinsp;2.90, 95% CI\u0026thinsp;=\u0026thinsp;1.20, 7.01, p\u0026thinsp;=\u0026thinsp;0.018), being in the ER due to drug or alcohol (OR\u0026thinsp;=\u0026thinsp;3.07, 95% CI\u0026thinsp;=\u0026thinsp;1.31\u0026ndash;7.16, p\u0026thinsp;=\u0026thinsp;0.010), illicit drug use (OR\u0026thinsp;=\u0026thinsp;2.25, 95% CI\u0026thinsp;=\u0026thinsp;1.09\u0026ndash;4.63, p\u0026thinsp;=\u0026thinsp;0.028), DAST score equal to or greater than 3 (OR\u0026thinsp;=\u0026thinsp;2.36, 95% CI\u0026thinsp;=\u0026thinsp;1.18\u0026ndash;4.70, p\u0026thinsp;=\u0026thinsp;0.015), and binge drinking (OR\u0026thinsp;=\u0026thinsp;2.41, 95% CI\u0026thinsp;=\u0026thinsp;1.25\u0026ndash;4.63, p\u0026thinsp;=\u0026thinsp;0.008). None of the partners\u0026rsquo; substance use behaviors were significantly associated with participants\u0026rsquo; reports of perpetration of IPV.\u003c/p\u003e \u003cp\u003e \u003cdiv class=\"gridtable\"\u003e\u003ctable float=\"Yes\" id=\"Tab7\" border=\"1\"\u003e \u003ccaption language=\"En\"\u003e \u003cdiv class=\"CaptionNumber\"\u003eTable 5\u003c/div\u003e \u003cdiv class=\"CaptionContent\"\u003e \u003cp\u003eActor-Partner Independence Models for Perpetrating IPV on Substance Abuse as Independent Variable (IV): Odds ratio, 95% confidence intervals and p-values\u003c/p\u003e \u003c/div\u003e \u003c/caption\u003e \u003ccolgroup cols=\"7\"\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c1\" colnum=\"1\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c2\" colnum=\"2\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c3\" colnum=\"3\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c4\" colnum=\"4\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c5\" colnum=\"5\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c6\" colnum=\"6\"\u003e\u003c/div\u003e \u003cdiv align=\"left\" class=\"colspec\" colname=\"c7\" colnum=\"7\"\u003e\u003c/div\u003e \u003cthead\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c1\" morerows=\"1\" rowspan=\"2\"\u003e\u0026nbsp;\u003c/th\u003e \u003cth align=\"left\" colspan=\"6\" nameend=\"c7\" namest=\"c2\"\u003e \u003cp\u003eOutcome: Perpetrating IPV\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003ctr\u003e \u003cth align=\"left\" colname=\"c2\"\u003e \u003cp\u003eModel 1 IV:\u003c/p\u003e \u003cp\u003eOverdose: ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c3\"\u003e \u003cp\u003eModel 2 IV:\u003c/p\u003e \u003cp\u003eIn ED due to drug or alcohol: ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c4\"\u003e \u003cp\u003eModel 3 IV:\u003c/p\u003e \u003cp\u003eIllicit drugs (excluding marijuana): ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c5\"\u003e \u003cp\u003eModel 4 IV:\u003c/p\u003e \u003cp\u003eDAST\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;3 (among drug users; n\u0026thinsp;=\u0026thinsp;367)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c6\"\u003e \u003cp\u003eModel 5 IV:\u003c/p\u003e \u003cp\u003eBinge drinking: ever (n\u0026thinsp;=\u0026thinsp;411)\u003c/p\u003e \u003c/th\u003e \u003cth align=\"left\" colname=\"c7\"\u003e \u003cp\u003eModel 6 IV:\u003c/p\u003e \u003cp\u003eCAGE\u0026thinsp;\u0026gt;\u0026thinsp;=\u0026thinsp;2 (among alcohol users; n\u0026thinsp;=\u0026thinsp;341)\u003c/p\u003e \u003c/th\u003e \u003c/tr\u003e \u003c/thead\u003e \u003ctbody\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eEffect Type\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eFemale actor\u0026rsquo;s effect\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1.04\u003c/p\u003e \u003cp\u003e[0.41, 2.66]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.924)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e2.41*\u003c/p\u003e \u003cp\u003e[1.02, 5.73]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.046)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1.21\u003c/p\u003e \u003cp\u003e[0.61, 2.40]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.578)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e2.10*\u003c/p\u003e \u003cp\u003e[1.07, 4.14]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.032)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e1.94*\u003c/p\u003e \u003cp\u003e[1.01, 3.73]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.048)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e1.89\u003c/p\u003e \u003cp\u003e[0.91, 3.92]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.087)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMale partner\u0026rsquo;s effects on female actors\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e1.77\u003c/p\u003e \u003cp\u003e[0.73, 4.30]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.210)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e0.71\u003c/p\u003e \u003cp\u003e[0.30, 1.69]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.437)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e1.14\u003c/p\u003e \u003cp\u003e[0.56, 2.30]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.725)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e0.71\u003c/p\u003e \u003cp\u003e[0.36, 1.37]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.315)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e0.78\u003c/p\u003e \u003cp\u003e[0.41, 1.49]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.453)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e0.99\u003c/p\u003e \u003cp\u003e[0.49, 2.01]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.980)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eEffect Type\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e\u0026nbsp;\u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e\u0026nbsp;\u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eMale actor effects\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e2.90*\u003c/p\u003e \u003cp\u003e[1.20, 7.01]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.018)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e3.07**\u003c/p\u003e \u003cp\u003e[1.31, 7.16]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.010)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e2.25*\u003c/p\u003e \u003cp\u003e[1.09, 4.63]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.028)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e2.36*\u003c/p\u003e \u003cp\u003e[1.18, 4.70]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.015)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e2.41**\u003c/p\u003e \u003cp\u003e[1.25, 4.63]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.008)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e1.81\u003c/p\u003e \u003cp\u003e[0.91, 3.58]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.089)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003ctr\u003e \u003ctd align=\"left\" colname=\"c1\"\u003e \u003cp\u003eFemale partner\u0026rsquo;s effects on male actors\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c2\"\u003e \u003cp\u003e0.63\u003c/p\u003e \u003cp\u003e[0.24, 1.71]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.367)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c3\"\u003e \u003cp\u003e0.89\u003c/p\u003e \u003cp\u003e[0.36, 2.19]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.797)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c4\"\u003e \u003cp\u003e0.92\u003c/p\u003e \u003cp\u003e[0.47, 1.78]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.796)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c5\"\u003e \u003cp\u003e1.42\u003c/p\u003e \u003cp\u003e[0.73, 2.78]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.304)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c6\"\u003e \u003cp\u003e0.86\u003c/p\u003e \u003cp\u003e[0.46, 1.63]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.651)\u003c/p\u003e \u003c/td\u003e \u003ctd align=\"left\" colname=\"c7\"\u003e \u003cp\u003e1.98\u003c/p\u003e \u003cp\u003e[0.96, 4.09]\u003c/p\u003e \u003cp\u003e(p\u0026thinsp;=\u0026thinsp;0.064)\u003c/p\u003e \u003c/td\u003e \u003c/tr\u003e \u003c/tbody\u003e \u003c/colgroup\u003e \u003ctfoot\u003e \u003ctr\u003e\u003ctd colspan=\"7\"\u003e* p\u0026thinsp;\u0026lt;\u0026thinsp;0.05, ** p\u0026thinsp;\u0026lt;\u0026thinsp;0.01\u003c/td\u003e\u003c/tr\u003e \u003c/tfoot\u003e \u003c/table\u003e\u003c/div\u003e \u003c/p\u003e"},{"header":"Discussion","content":"\u003cp\u003eOur results revealed significant actor effects, where one's own substance use was associated with both experiencing and perpetrating IPV. For men under community supervision, problematic drug use was associated with experiencing IPV, while multiple substance use measures (overdose, emergency room visits, illicit drug use, problematic drug use, and binge drinking) were associated with perpetrating IPV. For women partnered with criminal legal-involved men, emergency room visits due to substance use and problematic drug use were associated with both experiencing and perpetrating IPV.\u003c/p\u003e \u003cp\u003eOur findings identified significant sex differences in IPV and substance use associations. For women, experiencing IPV was significantly associated with emergency room visits and problematic drug use as measured by the DAST, whereas for men, experiencing IPV was only linked to problematic drug use. This suggests that women who experience IPV may use substances as coping mechanisms following victimization (\u003cspan citationid=\"CR23\" class=\"CitationRef\"\u003e23\u003c/span\u003e, \u003cspan citationid=\"CR25\" class=\"CitationRef\"\u003e25\u003c/span\u003e). Notably, we found no significant partner effects in our models examining IPV victimization, indicating that one's own substance use behaviors, rather than that of their partner, predicted their IPV experiences.\u003c/p\u003e \u003cp\u003eFor IPV perpetration, we found strong actor effects, but no significant partner effects. Men's perpetration was significantly associated with five substance use measures: overdose, emergency room visits, illicit drug use, problematic drug use, and binge drinking. Perpetration by women was associated with emergency room visits, problematic drug use, and binge drinking. These findings highlight substance use as a risk factor for IPV perpetration, potentially reflecting substance-induced disinhibition or underlying trauma contributing to both behaviors (\u003cspan citationid=\"CR16\" class=\"CitationRef\"\u003e16\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eWomen experiencing IPV often face barriers in accessing harm reduction and treatment resources, including controlling behaviors from partners and limited healthcare access (\u003cspan citationid=\"CR4\" class=\"CitationRef\"\u003e4\u003c/span\u003e, \u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e). The criminal legal system creates additional health inequities and barriers for overdose prevention. In the context of IPV, intimate partners may impede engagement with supervision requirements and inadvertently fuel mass supervision systems. Previous research using this dataset has demonstrated that couple-focused interventions can improve outcomes despite IPV exposure (\u003cspan citationid=\"CR3\" class=\"CitationRef\"\u003e3\u003c/span\u003e, \u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e). Our Actor-Partner Interdependence Model also revealed strong actor effects but no significant partner effects, suggesting one's own substance use behaviors—rather than their partner's—predict involvement with family violence. This pattern extends previous APIM analyses from previous analysis on the PACT project, which similarly found significant actor effects for injection drug use (\u003cspan citationid=\"CR41\" class=\"CitationRef\"\u003e41\u003c/span\u003e) and sexual HIV risk behaviors (\u003cspan citationid=\"CR42\" class=\"CitationRef\"\u003e42\u003c/span\u003e).\u003c/p\u003e \u003cp\u003eFuture research should explore evidence-based violence reduction strategies, including mental health treatment, conflict resolution skills, and appropriate involvement in law enforcement during conflicts, as well as develop couple-focused interventions like adapting Project PACT to address overdose prevention within intimate partnerships, focusing on relationship communication, couple satisfaction, and trust as key mechanisms for behavioral change. Research is also needed to interrupt contexts where IPV occurs, as violence often occurs when partners are under the influence of substances. People who perpetrate violence may use substances during heightened emotional states without ensuring naloxone access, and may exclude partners from overdose prevention planning. Understanding how violence perpetration affects drug use behaviors is critical. Perpetrators may be less likely to engage in harm reduction practices during emotional distress and may disrupt coordinated efforts to reduce drug use. Further research should explore evidence-based violence reduction strategies, including mental health treatment, conflict resolution skills, and appropriate involvement in law enforcement during conflicts.\u003c/p\u003e \u003cp\u003eOur findings and dyadic framework (Fig.\u0026nbsp;\u003cspan refid=\"Fig1\" class=\"InternalRef\"\u003e1\u003c/span\u003e) also illustrates how social determinants of health (sdoh) shape the dynamics of family violence and substance use among criminal legal-involved couples. The observed associations between housing instability, food insecurity, and IPV align with (\u003cspan citationid=\"CR43\" class=\"CitationRef\"\u003e43\u003c/span\u003e) research on how basic needs insecurity shapes health outcomes and (\u003cspan citationid=\"CR44\" class=\"CitationRef\"\u003e44\u003c/span\u003e) work demonstrating how stressful life events exacerbate both substance use and intimate partner conflict. The educational disparities we identified among male perpetrators align with findings from other criminal legal-involved populations where socioeconomic factors predicted both substance use and risk behaviors (\u003cspan citationid=\"CR40\" class=\"CitationRef\"\u003e40\u003c/span\u003e). These social determinants create a web of vulnerability where substance use and family violence become mutually reinforcing, supporting previous work on the intersectional nature of these challenges (\u003cspan citationid=\"CR1\" class=\"CitationRef\"\u003e1\u003c/span\u003e).\u003c/p\u003e \u003cp\u003e \u003c/p\u003e \u003cp\u003eThese findings underscore the need for integrated approaches that simultaneously address substance use and IPV among criminal legal involved couples. Interventions should target both individual substance use behavior and relationship dynamics to effectively reduce IPV and substance-related harm in this vulnerable population.\u003c/p\u003e "},{"header":"Limitations","content":"\u003cp\u003eThis study has several limitations that warrant consideration. First, our cross-sectional analysis, using only baseline RCT data, prevented causal inferences. The temporal relationship between substance use and IPV cannot be established with certainty, as substance use measures captured lifetime experiences, while IPV measures focused on the past three months. Second, self-reported data introduce potential recall and social desirability bias that could result in underreporting of both substance use and IPV. This may be particularly relevant for IPV perpetration, which shows a lower internal consistency reliability. Third, our sample selection criteria may have introduced biases that limit generalizability. Male participants were selected based on community supervision involvement and substance use, and couples were included based on HIV risk criteria, potentially resulting in a sample with higher rates of both substance use and IPV than those of the general population. Fourth, we examined each substance use variable in separate models to avoid multicollinearity; however, this approach does not account for the common co-occurrence of different substance use patterns. Finally, conclusions should be limited to heterosexual couples in which the male partner is involved in the criminal legal system in New York City. The data were collected between 2013–2016, and patterns of substance use and overdose risk have evolved substantially with the changing opioid crisis, particularly with the increased fentanyl prevalence in recent years.\u003c/p\u003e"},{"header":"Conclusion","content":"\u003cp\u003eThis study addresses an important gap in the literature by examining the dyadic interplay between IPV and substance use among heterosexual couples, where the male partner is involved in community supervision. These findings highlight the need for approaches that simultaneously address substance use, family violence, and the underlying social determinants that contribute to both, particularly within criminal legal settings that serve populations disproportionately affected by these intersecting challenges. As community supervision increasingly serves as an alternative to incarceration for people who use drugs, understanding the complex relationships between substance use, IPV, and criminal legal system involvement is becoming increasingly important for developing effective interventions and policies, that can help reduce the public health burden of both IPV and substance use-related harm among families for this population.\u003c/p\u003e"},{"header":"Declarations","content":"\u003cp\u003e\u003cstrong\u003eFunding\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThis study was funded by the National Institute of Drug Abuse (grant reference number: R01DA033168).\u0026nbsp;Two of the authors are supported by the National Institute on Drug Abuse of the National Institute of Health under Award Number T32DA037801.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eClinical Trial Information\u0026nbsp;\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003e\u003cu\u003eClinicaltrials.gov Trial Registration date\u003c/u\u003e: \u0026nbsp;2012-09-19. \u003cu\u003eClinicalTrials.gov ID:\u003c/u\u003e NCT01690494\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eInstitutional Review Board Statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Research Board at Columbia University, for studies involving humans.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eInformed Consent Statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eInformed consent was obtained from all subjects involved in the study.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eData Availability Statement\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe data presented in this study are available on request from the corresponding author. The data are not publicly available due to privacy and ethical reasons.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eAcknowledgments\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors are very grateful to the New York City Department of Probation and the Center for Court Innovation. We also want to thank the facilitators of the PACT intervention as well as the project\u0026apos;s research assistants. Finally, we wish to acknowledge the couples who participated in this study.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eConflicts of Interest\u003c/strong\u003e\u003c/p\u003e\n\u003cp\u003eThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. The funder had no role in any aspect of study design, study implementation, or analyses.\u003c/p\u003e\n\u003ch3\u003e\u003cstrong\u003eAuthorship contributions\u003c/strong\u003e\u003c/h3\u003e\n\u003cp\u003eD.G.E, P.M, N.D., L.G, M.C, J.H, T.H., A.D\u003cstrong\u003e\u0026nbsp;- Writing \u0026ndash; original draft and literature review;\u0026nbsp;\u003c/strong\u003eD.G.E, L.G, T.H, M.C\u003cstrong\u003e\u0026nbsp;- Data curation; \u0026nbsp;\u003c/strong\u003eN.E, L.G, E.W-\u003cstrong\u003e\u0026nbsp;Investigation;\u0026nbsp;\u003c/strong\u003eD.G.E L.G, E.W, M.C, A.D, T.H \u003cstrong\u003e\u0026ndash; Methodology;\u0026nbsp;\u003c/strong\u003eD.G.E, T.H, L.G, N.E\u003cstrong\u003e\u0026nbsp;- Project administration and Supervision; \u0026nbsp;\u003c/strong\u003eL.G, M.C, E.W., D.G.E\u003cstrong\u003e\u0026nbsp;- Conceptualization;\u0026nbsp;\u003c/strong\u003eN.E, L.G, E.W\u003cstrong\u003e\u0026nbsp;- Funding acquisition; \u0026nbsp;\u003c/strong\u003eD.G.E., P.M., N.D., M.C., E.W., A.R., \u0026nbsp;T.H., A.D., A.D., J.H., S.B., K.C., N.E, \u0026nbsp;L.G.,\u003cstrong\u003e\u0026nbsp;.: review \u0026amp; editing. All authors have read, provided critical review and agreed to the published the manuscript.\u003c/strong\u003e\u003c/p\u003e"},{"header":"References","content":"\u003col\u003e\u003cli\u003e\u003cspan\u003eGilbert L, Marotta PL, Goddard-Eckrich D, Richer A, Akuffo J, Hunt T, et al. Association Between Multiple Experiences of Violence and Drug Overdose Among Black Women in Community Supervision Programs in New York City. J Interpers Violence. 2022;37(23\u0026ndash;24):NP21502\u0026ndash;24.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eAtaiants J, Mazzella S, Roth AM, Robinson LF, Sell RL, Lankenau SE. Multiple Victimizations and Overdose Among Women With a History of Illicit Drug Use. J Interpers Violence. 2022;37(3\u0026ndash;4):NP1588\u0026ndash;613.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEl-Bassel N, Marotta PL, Goddard-Eckrich D, Chang M, Hunt T, Wu E et al. Drug overdose among women in intimate relationships: The role of partner violence, adversity and relationship dependencies. Carr\u0026agrave; G, editor. PLOS ONE. 2019;14(12):e0225854.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGilbert L, Goddard-Eckrich D, Hunt T, Ma X, Chang M, Rowe J, et al. Efficacy of a Computerized Intervention on HIV and Intimate Partner Violence Among Substance-Using Women in Community Corrections: A Randomized Controlled Trial. Am J Public Health. 2016;106(7):1278\u0026ndash;86.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGolder S, Hall MT, Logan T, Higgins GE, Dishon A, Renn T, et al. Substance Use Among Victimized Women on Probation and Parole. Subst Use Misuse. 2014;49(4):435\u0026ndash;47.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWaddell EN, Baker R, Hartung DM, Hildebran CJ, Nguyen T, Collins DM, et al. Reducing overdose after release from incarceration (ROAR): study protocol for an intervention to reduce risk of fatal and non-fatal opioid overdose among women after release from prison. Health Justice. 2020;8(1):18.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eVan Draanen J, Tsang C, Mitra S, Karamouzian M, Richardson L. Socioeconomic marginalization and opioid-related overdose: A systematic review. Drug Alcohol Depend. 2020;214:108127.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eUrahn SK, Conroy T, Schiff M, Bell E, Chao S, Huh K et al. More Imprisonment Does Not Reduce State Drug Problems [Internet]. The Pew Charitable Trusts; 2018. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2018/03/more-imprisonment-does-not-reduce-state-drug-problems\u003c/span\u003e\u003cspan address=\"https://www.pewtrusts.org/en/research-and-analysis/issue-briefs/2018/03/more-imprisonment-does-not-reduce-state-drug-problems\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSmith SG, Zhang X, Basile KC, Merrick MT, Wang J, Kresnow M et al. The National Intimate Partner and Sexual Violence Survey: 2015 data brief \u0026ndash; updated release [Internet]. Centers for Disease Control and Prevention; 2018. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://stacks.cdc.gov/view/cdc/60893\u003c/span\u003e\u003cspan address=\"https://stacks.cdc.gov/view/cdc/60893\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCarney M, Buttell F, Dutton D. Women who perpetrate intimate partner violence: A review of the literature with recommendations for treatment. Aggress Violent Behav. 2007;12(1):108\u0026ndash;15.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLanghinrichsen-Rohling J, Misra TA, Selwyn C, Rohling ML. Rates of Bidirectional Versus Unidirectional Intimate Partner Violence Across Samples, Sexual Orientations, and Race/Ethnicities: A Comprehensive Review. Partn Abuse. 2012;3(2):199\u0026ndash;230.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLow S, Tiberio SS, Shortt JW, Capaldi DM, Eddy JM. Associations of couples\u0026rsquo; intimate partner violence in young adulthood and substance use: A dyadic approach. Psychol Violence. 2017;7(1):120\u0026ndash;7.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKimmel MS. Gender Symmetry in Domestic Violence: A Substantive and Methodological Research Review. Violence Women. 2002;8(11):1332\u0026ndash;63.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eStraus MA. Dominance and symmetry in partner violence by male and female university students in 32 nations. Child Youth Serv Rev. 2008;30(3):252\u0026ndash;75.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eTemple JR, Weston R, Marshall LL. Physical and Mental Health Outcomes of Women in Nonviolent, Unilaterally Violent, and Mutually Violent Relationships. Violence Vict. 2005;20(3):335\u0026ndash;59.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eForan HM, O\u0026rsquo;Leary KD. Alcohol and intimate partner violence: A meta-analytic review. Clin Psychol Rev. 2008;28(7):1222\u0026ndash;34.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSmith PH, Homish GG, Leonard KE, Cornelius JR. Intimate partner violence and specific substance use disorders: Findings from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Addict Behav. 2012;26(2):236\u0026ndash;45.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eClements K, Schumacher JA. Perceptual biases in social cognition as potential moderators of the relationship between alcohol and intimate partner violence: A review. Aggress Violent Behav. 2010;15(5):357\u0026ndash;68.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eO\u0026rsquo;Leary KD, Schumacher JA. The association between alcohol use and intimate partner violence: Linear effect, threshold effect, or both? Addict Behav. 2003;28(9):1575\u0026ndash;85.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWatkins LE, Maldonado RC, DiLillo D. Hazardous alcohol use and intimate partner aggression among dating couples: The role of impulse control difficulties. Aggress Behav. 2014;40(4):369\u0026ndash;81.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eErnst AA, Weiss SJ, Enright-Smith S, Hilton E, Byrd EC. Perpetrators of intimate partner violence use significantly more methamphetamine, cocaine, and alcohol than victims: a report by victims. Am J Emerg Med. 2008;26(5):592\u0026ndash;6.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eChoenni V, Hammink A, Van De Mheen D. Association Between Substance Use and the Perpetration of Family Violence in Industrialized Countries: A Systematic Review. Trauma Violence Abuse. 2017;18(1):37\u0026ndash;50.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGilbert L, El-Bassel N, Rajah V, Foleno A, Frye V. Linking drug-related activities with experiences of partner violence: a focus group study of women in methadone treatment. Violence Vict. 2001;16(5):517\u0026ndash;36.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMartino SC, Collins RL, Ellickson PL. Cross-lagged relationships between substance use and intimate partner violence among a sample of young adult women. J Stud Alcohol. 2005;66(1):139\u0026ndash;48.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eRoberts TA, Klein JD, Fisher S. Longitudinal Effect of Intimate Partner Abuse on High-Risk Behavior Among Adolescents. Arch Pediatr Adolesc Med. 2003;157(9):875.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHien D, Hien NM, Women. Violence with Intimates, and Substance Abuse: Relevant Theory, Empirical Findings, and Recommendations for Future Research. Am J Drug Alcohol Abuse. 1998;24(3):419\u0026ndash;38.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDo QA, Knopp K, Scott SB. Intimate partner violence in female same-gender couples: An investigation of actor\u0026ndash;partner correlates within the past year. Psychol Trauma Theory Res Pract Policy. 2022;14(5):759\u0026ndash;68.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eLeone RM, Crane CA, Parrott DJ, Eckhardt CI. Problematic drinking, impulsivity, and physical IPV perpetration: A dyadic analysis. Psychol Addict Behav. 2016;30(3):356\u0026ndash;66.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eCook WL, Kenny DA. The Actor\u0026ndash;Partner Interdependence Model: A model of bidirectional effects in developmental studies. Int J Behav Dev. 2005;29(2):101\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eKelley ML, Lam N, Hernandez M, Miller MM, Mid-Atlantic VA. Workgroup. Modeling Risk for Intimate Partner Violence among Recent-Era Veteran-Partner Dyads. J Fam Violence. 2017;32(5):505\u0026ndash;12.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eNewcomb MD. A Dyadic Approach to Health, Cognition, and Quality of Life in Aging Adults. Springer; 2020.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eReed RG, Butler EA, Kenny DA. Dyadic Models for the Study of Health. Soc Personal Psychol Compass. 2013;7(4):228\u0026ndash;45.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEl-Bassel N, Gilbert L, Goddard-Eckrich D, Chang M, Wu E, Goodwin S, et al. Effectiveness of a Couple-Based HIV and Sexually Transmitted Infection Prevention Intervention for Men in Community Supervision Programs and Their Female Sexual Partners: A Randomized Clinical Trial. JAMA Netw Open. 2019;2(3):e191139.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eGoddard-Eckrich D, Duan R, Hunt T, Wu E, Chang M, El-Bassel N. The impact of a couple-based intervention on HIV/STI testing among male-female couples who inject drugs. AIDS Behav. 2022;26(7):2316\u0026ndash;26.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eWilliams N. The CAGE questionnaire. Occup Med. 2014;64(6):473\u0026ndash;4.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eEwing JA. Detecting Alcoholism: The CAGE Questionnaire. JAMA. 1984;252(14):1905.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eJensen N. Development of a novel measure to assess for alcohol misuse in older adults: The Alcohol Misuse Scale for Older Adults (AMSOA) [Internet] [Thesis]. Georgia Southern University; 2024. Available from: \u003cspan class=\"ExternalRef\"\u003e\u003cspan class=\"RefSource\"\u003ehttps://digitalcommons.georgiasouthern.edu/etd/2541\u003c/span\u003e\u003cspan address=\"https://digitalcommons.georgiasouthern.edu/etd/2541\" targettype=\"URL\" class=\"RefTarget\"\u003e\u003c/span\u003e\u003c/span\u003e\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eSkinner HA. The drug abuse screening test. Addict Behav. 1982;7(4):363\u0026ndash;71.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eStraus MA, Hamby SL, BONEY-McCOY S, Sugarman DB. The Revised Conflict Tactics Scales (CTS2): Development and Preliminary Psychometric Data. J Fam Issues. 1996;17(3):283\u0026ndash;316.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMarotta PL, Terlikbayeva A, Gilbert L, Davis A, Wu E, Metsch L, et al. Dyadic analysis of criminal justice involvement and hiv risks among couples who inject drugs and their intimate partners in almaty, kazakhstan. Int J Drug Policy. 2021;87:102950.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDavis A, Pala AN, Gilbert L, Marotta PL, Goddard-Eckrich D, El-Bassel N. Using actor-partner interdependence modeling to understand recent illicit opioid use and injection drug use among men in community supervision and their female partners in New York City. Int J Drug Policy. 2020;83:102843.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eMarotta PL, Gilbert L, Goddard-Eckrich D, Hunt T, Metsch L, Davis A, et al. A Dyadic Analysis of Criminal Justice Involvement and Sexual HIV Risk Behaviors Among Drug-Involved Men in Community Corrections and Their Intimate Partners in New York City: Implications for Prevention, Treatment and Policies. AIDS Behav. 2021;25(4):1047\u0026ndash;62.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eDsouza N, Gilbert L, Russo M, Johnson K, Chang M, Dasgupta A, et al. The Influence of Housing Status and Food Insecurity on a Behavioral HIV/STI Prevention Intervention for Black Women under Community Supervision in New York City: A Moderation Analysis. AIDS Behav. 2024;28(9):3161\u0026ndash;9.\u003c/span\u003e\u003c/li\u003e \u003cli\u003e\u003cspan\u003eHenry BF, Mandavia AD, Paschen-Wolff MM, Hunt T, Humensky JL, Wu E, et al. COVID-19, mental health, and opioid use disorder: Old and new public health crises intertwine. Psychol Trauma Theory Res Pract Policy. 2020;12(S1):S111\u0026ndash;2.\u003c/span\u003e\u003c/li\u003e\u003c/ol\u003e"}],"fulltextSource":"","fullText":"","funders":[],"hasAdminPriorityOnWorkflow":false,"hasManuscriptDocX":true,"hasOptedInToPreprint":true,"hasPassedJournalQc":"","hasAnyPriority":false,"hideJournal":true,"highlight":"","institution":"","isAcceptedByJournal":false,"isAuthorSuppliedPdf":false,"isDeskRejected":"","isHiddenFromSearch":false,"isInQc":false,"isInWorkflow":false,"isPdf":false,"isPdfUpToDate":true,"isWithdrawnOrRetracted":false,"journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true},"keywords":"Actor-Partner Interdependence Model, IPV, Couples, drug use, criminal legal system","lastPublishedDoi":"10.21203/rs.3.rs-6676375/v1","lastPublishedDoiUrl":"https://doi.org/10.21203/rs.3.rs-6676375/v1","license":{"name":"CC BY 4.0","url":"https://creativecommons.org/licenses/by/4.0/"},"manuscriptAbstract":"\u003cp\u003e\u003cstrong\u003eBackground:\u003c/strong\u003e When examining the relationship between intimate partner violence (IPV) and substance use, most studies have focused exclusively on individual-level correlates without considering cross-partner associations. Given the bidirectional nature of IPV within intimate relationships, a dyadic (couple) approach may assist in gaining a more precise understanding of the complex interrelationships between IPV, substance use, and overdose risks among couples.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eMethods:\u003c/strong\u003e We employed the Actor-Partner Interdependence Model (APIM) using baseline data from a randomized controlled trial to examine how perpetration and experience of IPV in the past three months may be associated with substance use and non-fatal overdose risks among men in community supervision programs in New York City and their intimate partners (N=412 participants; 212 male and 196 female). The actor and partner effects were estimated using a multilevel logistic regression model with membership of a couple as a random effect for partner dependency, adjusting for key demographic factors.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eFindings:\u003c/strong\u003e Over one-third of the participants (n=157, 38.1%) reported experiencing IPV and perpetrating IPV (n=149, 36.2%). Female participants who had been in the ER due to drugs or alcohol were more likely to report experiencing IPV (OR=2.62, 95% CI=1.02-6.88, p=0.046) and perpetrating IPV (OR=2.41, 95% CI=1.02-5.73, p=0.046) than those who had not been in the ER. Male participants who had been in the ER due to drugs or alcohol were also more likely to report perpetrating IPV (OR=3.07, 95% CI=1.31-7.16, p=0.010). Male participants who had experienced overdose were more likely to report perpetrating IPV than those who had not (OR=2.90, 95% CI=1.20, 7.01, p=0.018). No partner effects of overdose risks were significantly associated with participants’ reports of IPV.\u003c/p\u003e\n\u003cp\u003e\u003cstrong\u003eImplications for D\u0026amp;I Research:\u003c/strong\u003e Our findings suggest a complex relationship between IPV and substance use behaviors, with primarily actor effects, but no significant partner effects. Understanding these relationships is important for developing integrated interventions that address both IPV and substance use risks among tice-involved populations. Such approaches may help address racial health inequities in drug overdose rates among non-Hispanic Black and Latinx populations, who are disproportionately impacted by the criminal legal system due to racialized drug laws and policing.\u003c/p\u003e","manuscriptTitle":"Intersections of Substance Use, Overdose Risk, and Intimate Partner Violence: A Dyadic Approach to Violence Prevention in Criminal Legal Settings","msid":"","msnumber":"","nonDraftVersions":[{"code":1,"date":"2025-05-26 01:59:59","doi":"10.21203/rs.3.rs-6676375/v1","editorialEvents":[{"type":"communityComments","content":0}],"status":"published","journal":{"display":true,"email":"
[email protected]","identity":"researchsquare","isNatureJournal":false,"hasQc":true,"allowDirectSubmit":true,"externalIdentity":"","sideBox":"","snPcode":"","submissionUrl":"/submission","title":"Research Square","twitterHandle":"researchsquare","acdcEnabled":true,"dfaEnabled":false,"editorialSystem":"","reportingPortfolio":"","inReviewEnabled":false,"inReviewRevisionsEnabled":true}}],"origin":"","ownerIdentity":"53020989-4a32-4a57-8f22-adb7f17ddb05","owner":[],"postedDate":"May 26th, 2025","published":true,"recentEditorialEvents":[],"rejectedJournal":[],"revision":"","amendment":"","status":"posted","subjectAreas":[],"tags":[],"updatedAt":"2025-09-04T06:23:54+00:00","versionOfRecord":[],"versionCreatedAt":"2025-05-26 01:59:59","video":"","vorDoi":"","vorDoiUrl":"","workflowStages":[]},"version":"v1","identity":"rs-6676375","journalConfig":"researchsquare"},"__N_SSP":true},"page":"/article/[identity]/[[...version]]","query":{"redirect":"/article/rs-6676375","identity":"rs-6676375","version":["v1"]},"buildId":"8U1c8b4HqxoKbykW_rLl7","isFallback":false,"isExperimentalCompile":false,"dynamicIds":[84888],"gssp":true,"scriptLoader":[]}
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.